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ABSTRACT
Breast cancer, surpassing lung cancer with the highest estimated new cases, is
closely associated with obesity. Cancer research continues to divulge the complexity of the
disease including the recognition that stromal cells must cooperate with the cancerous
epithelium for cancer growth and metastasis.
Parabens are a class of esters of 4-hydroxybenzoic acid that is ubiquitous in the
environment, and act as anti-microbial agents that sustain the shelf-life of personal care
products, pharmaceuticals, food, etc. Parabens are classified as endocrine disrupting
chemicals, are estrogenic, and bioaccumulate within adipose tissue.
Activation of fibroblasts is caused by tissue damage leading to the release of
inflammatory cytokines to stimulate wound healing. Low dose (0.02, 0.1, and 1 μM)
methyl-, propyl, and butylparaben (MP, PP, and BP) treatment onto murine 3T3-L1 and
human primary breast (BRF) fibroblasts led to an inflammatory response by the
upregulation of inflammatory cytokines including interleukin-1β

(IL-1β)

and

cyclooxygenase-2 (COX2) via activation of the NF-κB pathway (Chapter III). MP, PP, and
BP also upregulated matrix metalloproteinase-9 (MMP9), indicating potential influence in
metastasis. Paraben-treated fibroblasts also increased the mRNA expression of CYP19A1
otherwise known as aromatase, which influences the conversion of androgen to estradiol.
Secretions from paraben-treated fibroblasts also obtained the ability to enhance
proliferation of estrogen receptor positive (ER+) breast cancer cells (MCF7).
To evaluate the contribution of adipocytes, 3T3-L1 and BRF adipocytes were
treated with MP, PP, and BP and induced upregulation IL-1β, COX2, MMP9, and
CYP19A1 (Chapter IV). The secretions from paraben-treated adipocytes also enhanced the
proliferation of MCF7 cells.
In conclusion, we have shown that environmental achievable low doses of parabens
enhance the inflammatory response of stromal fibroblasts and adipocytes, and the
secretions produced from paraben exposure enhance the proliferation of breast cancer cells.
Our results support the existing evidence that paraben exposure may lead to increased risks
of breast cancer and suggest the stromal link between parabens and breast cancer. Further
iv

studies are warranted to confirm the effects of parabens on breast stromal cells and
carcinogenesis in vivo and to establish the role of NF-B pathway.
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CHAPTER 1 :
INTRODUCTION
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Breast cancer is a complex disease with a variety of different classifications, including
location of abnormal cells, level of invasiveness, hormone receptor expression, and age of
onset (Figure 1.1.) (Harbeck, Penault-Llorca et al. 2019). The breast is composed of a
network of alveoli, comprised of milk-secreting epithelial cells, which are connected to
form a breast lobule (Macias and Hinck 2012). A multitude of lobules is connected to
lactiferous ducts, all of which form the mammary gland (Macias and Hinck 2012).
Abnormal cells can be found in either the milk duct epithelium, ductal carcinoma, or lobule
epithelium, lobular carcinoma (Hong, McMasters et al. 2018). As the abnormal cells
remain within the epithelium, cancer is classified as in situ; however, as they spread into
neighboring regions, cancer is classified as invasive (Hong, McMasters et al. 2018).
Hormone receptor (HR) expression, particularly estrogen (ER) and progesterone (PR), as
well as human epidermal growth factor receptor 2 (HER2) expression, are typical markers
to classify breast cancers and provide avenues for treatment (Harbeck, Penault-Llorca et
al. 2019). HER2 is a protein that functions as a growth factor activating signaling pathways
such as mitogen-activated protein kinase (MAPK), phosphoinositide 3-kinase (PI3K/Akt),
phospholipase C, protein kinase C (PKC), and signal transducer and activator of
transcription all leading to cellular proliferation (Harbeck, Penault-Llorca et al. 2019).
Breast cancers are often categorized based on patient’s age as either pre-menopausal or
post-menopausal. Before menopause women produce estrogens primarily from the ovaries.
However, ovarian estrogen cessation occurs after menopause causing other tissues to
become the major estrogen producers (Amadou, Ferrari et al. 2013, Neuhouser, Aragaki et
al. 2015).

Approximately 48,100 cases of non-invasive ductal carcinoma in situ (DCIS) and 268,600
cases of invasive cancer are estimated in 2019 (DeSantis, Ma et al. 2019). The majority of
new diagnoses occur in post-menopausal women with HR+/HER2- expression (DeSantis,
Ma et al. 2019). Treatments have proven to be effective over time as death rates have been
decreasing since 1995 (DeSantis, Ma et al. 2019). However, incidence rates remain
constant over the last 15 years (DeSantis, Ma et al. 2019). In attempts to prevent breast
cancer occurrence, many factors outside of genetics have been identified to be associated
2

with breast cancer including obesity, exposure to xenoestrogens, etc. (Bandera, Maskarinec
et al. 2015, Neuhouser, Aragaki et al. 2015). Obesity in postmenopausal women has a direct
association with the risk of breast cancer (Chan, Vieira et al. 2014, Arnold, Jiang et al.
2016). However, controversially higher adiposity in premenopausal women appears to be
protective against breast cancer and associated with lower risk of premenopausal breast
cancer (Nichols, Schoemaker et al. 2017).

A breast cancer tumor is comprised of more than abnormal epithelial cells, but a
conglomerate of other cell types surround these epithelial cells and have been found to
communicate via paracrine factors (Radisky and Radisky 2007, Bussard, Mutkus et al.
2016, Semenza 2016). This surrounding microenvironment, or stroma, of cells consists of
fibroblasts, adipocytes, immune cells, macrophage, endothelial cells, mast cells, etc.
(Figure 1.2.) (Soysal, Tzankov et al. 2015). Stromal inflammation has been identified in
breast cancer patients’ biopsies, which are linked with worse prognosis (Radisky and
Radisky 2007, Majidinia and Yousefi 2017). Obesity leads to chronic inflammation, which
in turn can influence local stromal inflammation permitting breast proliferation and
progression (Brown 2014, Allen and Jones 2015, Agresti, Meneghini et al. 2016). Breast
cancer occurs in stages with the worst stage being metastasis, and stromal inflammation is
closely linked with breast cancer progression to metastasis (Soysal, Tzankov et al. 2015,
Suhail, Cain et al. 2019).

Environmental chemicals, such as parabens, found in personal care products, food and
household items that have been observed to accumulate in breast cancer tissue and adipose
tissue (Barr, Metaxas et al. 2012, Harvey and Everett 2012, Wang, Asimakopoulos et al.
2015). The identification of parabens within breast tissue of cancer patients leads to an
increasing intrigue in the characterization of parabens' actions in breast cancer
development. Parabens have been shown to be estrogenic in nature and to directly promote
epithelial cell growth (Charles and Darbre 2013, Darbre and Harvey 2014). However, it is
unclear whether parabens can induce changes in the stromal fibroblasts and adipocytes to
produce an inflamed stroma.
3

It is well recognized that aggressive cancerous epithelial cells must acquire the “hallmarks”
of cancer, which include evading suppressors, resisting cell death, replicating, eliciting
vascularization, initiating tissue invasion, acquiring unlimited energy, evading immune
targeting, and sending proliferation signals to survive (Hanahan 2011, Darbre and Harvey
2014). The stroma must provide the necessary support to the cancerous cells to meet these
hallmarks. As parabens are detected in breast cancer tissue, it is conceivable that these
chemicals could contribute to this carcinogenic stroma. Our previous studies have
demonstrated parabens’ ability to create an obesogenic stroma by forcing fibroblasts to
differentiate into adipocytes (Hu, Chen et al. 2013). Previous results also suggest that
parabens may negatively change stromal cells, creating a carcinogenic stroma that has proinflammatory, pro-angiogenic and pro-mitogenic characteristics.

In this dissertation, the stromal fibroblasts and adipocytes were subjected to three different
types of most common parabens, methyl- (MP), propyl- (PP), and butylparaben (BP) to
characterize their inflammatory effects. We hypothesize that at environmentally achievable
doses parabens can influence stromal (1) fibroblasts (Chapter 3) and (2) adipocytes
(Chapter 4) using both murine 3T3-L1 and human breast stromal cells.
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1.2.

Appendix

Figure 1.1. Characterization of breast cancer.
Physiology of human breast demonstrating the essential anatomy to understanding breast
cancer types. Identifying four common ways of classifying breast cancer based on location,
invasiveness, receptor expression, and age of onset. Adapted from: Harbeck N, PenaultLlorca F, Cortes J, et al. Breast Cancer. Nat Rev Dis Primers. 2019;5(66):1-31.
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Figure 1.2: Diagram of breast tumor microenvironment.
Demonstration of the cellular connectivity and interactions between cells within the tumor
stroma.
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CHAPTER 2 :
LITERATURE REVIEW
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2.1.

Introduction

Breast cancer remains the second leading cause of cancer-related deaths in women in the
United States behind lung and bronchial cancers in 2018 (DeSantis, Ma et al. 2019). This
trend has occurred since the 1960s when uterine and colon cancer deaths in women began
to decline (DeSantis, Ma et al. 2019). However, awareness, screening, and treatment
advancements have aided in lowering the death rates of breast cancer by 39% from 1989
to 2015 (DeSantis, Ma et al. 2019). Invasive breast cancer incidence rates have remained
stable from 2005 to 2014 (DeSantis, Ma et al. 2019).

The occurrence of breast cancer is a result of the compounding effects of risk factors to
which women are exposed. The risk factors for breast cancer can be grouped into nonmodifiable factors (family history and hereditary gene) and modifiable (environmental)
factors (Darbre 2006). The familial risk factors include a family history of breast cancer,
other breast diseases, or high breast density. The hereditary risk factor is the individual that
has inherited a BRCA1, BRCA2, or other breast cancer-related gene mutations. Nonmodifiable risk factors only account for approximately 5-10% of breast cancers, whereas
90% of breast cancer occurrence is thought to be related to modifiable, environmental
factors (Darbre 2006). There are many environmental risk factors, such as obesity,
sedentary lifestyle, oral contraceptives, xenoestrogens, etc., and exposures that are
modifiable and are associated with increased breast cancer risk. Additionally, nulliparity,
having first child after the age of 30, and postmenopausal hormone use are also considered
breast cancer risks (ACS 2018).

It is increasingly recognized that exposure to environmental chemicals is associated with
increased risks of developing breast cancer. Many of such environmental chemicals, such
as bisphenol A, atrazine, benzophenone-1 and nonylphenol, are reported to be estrogenic
and are thought to be implicated in breast carcinogenesis (Burks, Pashos et al. 2017).
Parabens are a class of these environmental chemicals, and recent evidence has suggested
that parabens are estrogenic and are implicated to impact a variety of physiological
abnormalities from reproduction to cancer (Smith, Souter et al. 2013, Darbre and Harvey
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2014, Guerra, Sanabria et al. 2017). Recently, significant progress has been made on the
relationship between parabens and breast cancer. In this review, a new understanding of
parabens’estrogenic effects, mechanisms of action, and their effects on breast cancer
development and progression are summarized.

2.2.

Parabens, Endocrine Disruptors, and Breast Cancer

2.2.1. Human Paraben Exposure
Parabens, 4-hydroxybenzoic acid alkyl esters, are absorbed or ingested daily from personal
care products (such as cosmetics, lotions, deodorants, hair care products, and shaving
products), pharmaceuticals and foods (Darbre and Harvey 2014). Parabens enter into the
body through dermal or gastrointestinal absorption and are distributed systemically
demonstrated by isolation of intact paraben in tissue, blood, breast milk, placenta, and urine
(Sandanger, Huber et al. 2011, Kolatorova 2017, Shen, Liang et al. 2017).

The four most common parabens present in biological fluids are methylparaben (MP),
ethylparaben (EP), propylparaben (PP) and butylparaben (BP), in order of increasing side
chain length (Sandanger, Huber et al. 2011, Darbre and Harvey 2014, Zhou, Chen et al.
2018). Parabens can either get metabolized by esterases in the gastrointestinal tract, liver,
or dermis for excretion or can travel through circulation to tissues for metabolism or
bioaccumulation (Wang, Asimakopoulos et al. 2015, Kolatorova 2017). MP is the most
abundant in systemic fluids as the metabolic rate of esterases increases with the size of the
paraben’s side chain. Additionally, these chemicals have a weak affinity for human serum
albumin allowing for greater accessibility to peripheral tissues (Greige-Gerges, Kaissi et
al. 2013).

As parabens are ubiquitously utilized in industry as an anti-microbial reagent to preserve
products and increase shelf-life, there is an increasing amount of evidence indicating
human exposure to parabens are ubiquitous as well. The estimated total intake of parabens
from food has been estimated to range from 307 – 940 ng/kg body weight, and absorption
differs depending on age with infants having the highest total absorption due to application
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of personal care products (Darbre and Harvey 2014). However, the estimated total intake
of parabens via personal care product usage ranges from 31 – 766 µg/kg body weight (bw)
again with infants being at the upper limit (Darbre and Harvey 2014). Women have higher
urine concentrations of parabens as compared to men (Zhou, Chen et al. 2018). The total
concentrations of parabens in men’s urine ranges from 0.5-79.1 ng/mL, whereas women
range from 17-237 ng/mL (Zhou, Chen et al. 2018). As personal care product usage leads
to a greater systemic level of parabens, previous research has identified the effect of skin
cream usage and systemic paraben levels. The positive correlation between the percentage
of skin area creamed per day and median plasma level of MP demonstrates the direct
connection between personal care products with paraben absorption and systemic
distribution (Sandanger, Huber et al. 2011). This association between cosmetic
applications and paraben burden can be confirmed by the disappearance of
isopropylparaben and isobutylparaben in all urine samples after a ban was imposed in 2014
on the utilization of these two chemicals in cosmetics (Zhou, Chen et al. 2018).

2.2.2. Parabens are EDCs
Parabens are endocrine disrupting chemicals (EDCs), which have the ability to alter the
normal endocrine function and cause adverse effects in development, reproduction,
neurology, and immunity (NIEHS 2018). The most common examples of EDCs are
parabens, dioxins, polychlorinated biphenyls, bisphenol A, etc. found in products like
pesticides, plastics, detergents, food, toys, cosmetics, and pharmaceuticals (NIEHS 2018).
Many EDCs have been identified as possessing estrogenic properties that increase the basal
estradiol levels, which in post-menopausal women can lead to exacerbated breast epithelial
cell proliferation and tumor growth (Darbre 2006, Yager 2006, Rodgers, Udesky et al.
2017).

Epidemiological evidence directly linking EDC exposure with breast cancer is limited due
to the vast amount of exposure variability. As EDCs are commonly used as preservatives
in consumables and hygiene productions, absorption occurs through ingestion, dermal
contact, and inhalation (Kolatorova 2017). Therefore, increased personal care product
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usage leads to greater exposure to EDCs, and women have higher levels of EDCs in bodily
fluids as compared to men due to the increased usage of cosmetics and lotions (Zhou, Chen
et al. 2018). Previously, individual EDCs are often identified as having a weak estrogenic
effect making their association with breast cancer negligible (Pastor-Barriuso, Fernandez
et al. 2016). However, prolonged daily exposure, bioaccumulation, and interactions of
xenoestrogens can invoke local and systemic endocrine changes (Pastor-Barriuso,
Fernandez et al. 2016).

It has been demonstrated that urban communities have a three- to four-fold increased risk
of estrogen receptor (ER) positive breast cancer compared to rural communities (Dey,
Soliman et al. 2010, Dey, Soliman et al. 2010). In Egypt, more urban areas had a higher
incidence of total and ER+ breast cancer from 2001-2006 and uterine cancer from 19992002 with little differences in nutritional status, length of breastfeeding, childbearing age,
etc. (Dey, Hablas et al. 2010, Dey, Soliman et al. 2010). Female cancers without hormonal
etiology, such as leukemia, are less stratified between urban and rural communities,
suggesting a hormonal contribution in the urban lifestyle (Dey, Hablas et al. 2010). It is
possible that the greater use of plastics, insecticides, detergents, personal care products,
and cosmetics in urban as compared to rural communities increases the EDC absorption
leading to a greater xenoestrogen burden.

2.2.3. Parabens and Breast Cancer
As parabens have been identified to increase breast cancer growth in vitro, extractions of
breast tissue from serial locations from the axilla to sternum were analyzed for paraben
presence (Barr, Metaxas et al. 2012, Darbre and Harvey 2014). The tissue levels of MP is
16.6 ng/g of tissue, which is greater than previously documented (Darbre, Aljarrah et al.
2004, Barr, Metaxas et al. 2012). Additionally, the concentration of PP in breast tissues is
found to be 16.8 ng/g of tissue, higher than MP. BP, EP, and isobutylparaben (IBP) are all
present at lower levels (5.5, 3.4, and 2.1 ng/g of tissue respectively) with a total paraben
concentration of 85.5 ng/g of tissue (Darbre and Harvey 2014). However, there is no
significant association between serial paraben localization and known patient tumor
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location (Barr, Metaxas et al. 2012). Parabens have greater bioaccumulation within the
outer region (axilla and lateral) of the breast than inner regions (mid and medial) (Barr,
Metaxas et al. 2012). The mammary glands are centrally located in the inner regions, while
the outer regions consist more of adipose tissue. The lack of association between paraben
levels and percent of breast density confirms the lower presence of parabens within the
inner regions (Sprague, Trentham-Dietz et al. 2013). Parabens localized in the outer region
of the breast is speculated to be caused by the use of deodorants (Barr, Metaxas et al. 2012).
However, an alternative hypothesis could be that the parabens are accumulating in the
adipose tissue of the breast as parabens are suggested to be the most abundant
environmental phenol present in adipose (Wang, Asimakopoulos et al. 2015).

2.3.

Estrogenic Effects of Parabens

2.3.1. Estrogenicity
Parabens have been identified to bind ER receptors and affect ER-related gene expression.
The estrogenic response is also attenuated with the pre-treatment of an ER inhibitor (ICI
182,780). In addition, parabens increase uterine weight, which is a classic physical
outcome that indicates estrogenic activity. The influence of parabens on ER increases with
the length of the alkyl chain and with the branching of the side chain. Moreover, MP, EP,
PP, BP, and BenzP have been calculated to have an estradiol equivalence factor (EEF) of
1.25(10-7), 6.48(10-7), 2.39 (10-6), 8.09(10-6), and 1.3(10-5) respectively, confirming the
increase in estrogenicity with increasing alkyl side chain length (Lange, Kuch et al. 2014).
MP and EP produce binding energies of -49.35 and -53.38 kcal/mol when automated
docking into human ERα ligand-binding domain (LBD) is conducted (Sun, Yu et al. 2016).
This release of energy indicates binding confirming the formation of hydrogen bonds in
the LBD at Glu353/Arg394 with the hydroxyl group of the parabens (Sun, Yu et al. 2016).

In addition to cell models demonstrating estrogenic effects, the standard for measuring
estrogenic activity in the animal model is determined by evaluating the uterine weight
changes upon paraben exposure. Parabens' estrogenicity has been demonstrated in CD-1
mice (Lemini 1997). Recently, the lowest-observed-effect levels (LOEL) for MP and EP
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to increase relative uterine weight in Sprague-Dawley (SD) rats was reported to be 20
mg/kg bw/day and 4 mg/kg bw/day (Sun, Yu et al. 2016). The no-observed-effect levels
(NOEL) are similar to previous publications at 4 mg/kg bw/day for MP and 0.8 mg/kg
bw/day for EP, which is similar to the upper limit of human paraben absorption (Lemini
1997, Sun, Yu et al. 2016). In addition to increases in uterine weight, paraben induced
significantly higher levels of estrogen responsive biomarkers compared to control animals
including intestinal calcium-binding protein (icabp), integral membrane-associated protein
1 (itmap1), calbindin-D 9k (CaBP-9k), and progesterone receptor (PR) in the rat uterine
tissue (Sun, Yu et al. 2016).

2.3.2. Mammary Tissue Development
The mammary gland is an intricate network of ducts that are surrounded by a stroma that
changes throughout different stages of life (Macias and Hinck 2012). The mammary gland
consists of epithelial ducts expanding from the nipple into a fat pad formed by adipocytes,
endothelial cells, fibroblasts, etc. with a function to secrete milk for newborn survival
(Macias and Hinck 2012). During the pubertal phase, mammary glands begin to develop
with scattered ducts lined with two layers of epithelial cells termed mammary tree (Macias
and Hinck 2012, Howard and Lu 2014). The breast epithelium is comprised of luminal
cells that line the ducts and of myoepithelial cells (Arendt and Kuperwasser 2015). In
humans, the ends of the ducts terminate in a fibroblastic stroma (Howard and Lu 2014).
Mammary tissue development in women begins during puberty and continually has
morphology changes as a woman enters pregnancy, lactation, and post-lactation (Howard
and Lu 2014, Arendt and Kuperwasser 2015). When a woman enters puberty the
myoepithelial cells within ducts proliferate in response to estrogen and progesterone
(Russo 1999, Arendt and Kuperwasser 2015). Estrogen induces the growth of mammary
ducts in cooperation with growth factors by activating the estrogen receptors located in
both the epithelium and stromal cells (Silberstein 1982). Pregnancy leads to morphological
changes within breasts including epithelial growth to form milk-secreting alveoli and
adipose tissue recession (Macias and Hinck 2012). Once lactation is complete, a process
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of involution begins when epithelial cells sense stagnant milk and begin to revert back to
the pre-pregnancy structure (Macias and Hinck 2012).

Methylparaben exposure at a low dose that was previously determined to produce urinary
metabolite concentrations comparable to those found in US population, in the perinatal and
prepubertal time periods caused less development of adipose tissue but increased ductal
tree expansion within the fat pad and growth of the glandular tissue, respectively, in SD
female rats (Gopalakrishnan, Teitelbaum et al. 2017). Female SD rats were treated with
MP or triclosan (TCS) at 0.105 and 0.05 (mg/kg/day), representing 1/10,000 and 1/1,000
no observed adverse effect levels (NOAEL) of these chemicals respectively. These low
doses were previously determined to produce urinary metabolite concentrations
comparable to those reported for the US population (Gopalakrishnan, Teitelbaum et al.
2017). Pubertal MP exposure induced more glandular tissue with a high degree of
branching in the SD female rats, which was associated with differential expression of 295
genes (Gopalakrishnan, Teitelbaum et al. 2017). Moreover, it was found that pubertal MP
exposure up-regulated or down-regulated subsets of genes that were also up-regulated or
down-regulated in breast cancers compared to nearby normal tissues (Gopalakrishnan,
Teitelbaum et al. 2017). Paraben exposure, therefore, at a prepubescent age can affect
breast tissue development by stimulating epithelial cell growth.

2.3.3. Menstrual Cycles
The menstrual cycles of women are managed by the alterations in hormones that occur in
a cyclical pattern. There are both steroidal and non-steroidal hormones secreted that
contribute to these changes, and the two most abundant and well-identified steroidal
hormones include estradiol and progesterone (Messinis, Messini et al. 2014). Estradiol,
secreted from the follicle, plays a primary role in the follicular phase of the menstrual cycle
(Messinis, Messini et al. 2014). In the follicular phase, which involves the oogenesis and
maturation, luteinizing hormone (LH) and follicle-stimulating hormone (FSH) increase
stimulating the release of estradiol (Messinis, Messini et al. 2014). During the peak of these
hormone levels, the oocyte is released from the follicle and ovulation occurs. The surge of
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LH and FSH elicit higher levels of estradiol and progesterone in the luteal phase. Estrogen
and progesterone induce negative feedback on the hypothalamic-pituitary-gonadal axis in
which it decreases the production of LH and FSH (Messinis, Messini et al. 2014).
Therefore, by the end of the luteal phase, LH and FSH are returning to normal levels along
with estrogen and progesterone signaling the beginning of a new cycle and menses.

Parabens can also influence the menstrual cycles in women due to estrogenic properties
determined by comparing bleeding records with urinary concentrations of parabens. In 127
premenopausal women of normal body mass index (BMI), the urinary concentrations of
parabens were similar to that of US females at 137, 1.3, 29.1, and 0.50 ng/mL for MP, EP,
PP, and BP. When estrogen-equivalent total paraben (ETP) of the four parabens was
calculated, high urinary ETP and BP concentrations were associated with a shorter
menstrual cycle (Nishihama, Yoshinaga et al. 2016). It is suggested that the greater levels
of basal estrogen from the simulation by parabens could initiate the negative feedback loop
more frequently, thereby inhibiting the amount of LH and FSH production and
consequently, the LH surge and ovulation.

2.4.

Mechanisms of Action by Parabens

2.4.1. Estrogen Receptor
As discussed in the previous section, parabens have the ability to bind ER and activate ER
signaling (Lange, Kuch et al. 2014, Sun, Yu et al. 2016). Additionally, they increase the
gene and protein expression of ER (ESR1 and ESR2, their alternative names ERα and ERβ)
(Wrobel and Gregoraszczuk 2014). ESR1 functions in cellular proliferation of mammary
gland cells, while ESR2 functions by antagonizing ESR1. ESR1 over-expression is linked
to breast cancer, while ESR2 expression is lost in breast cancer patients. MP, PP, and BP
at 20 nM significantly enhanced ESR1 and ESR2 mRNA expression upon 24 h of treatment
in MCF7 cells. MP and PP also increased ESR1 mRNA expression in normal breast
epithelial cells (MCF10A) at 6 h (Wrobel and Gregoraszczuk 2014).
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ERα protein (ESR1 product) expression was greatly enhanced by MP, PP, and BP at 48 h
than by estradiol, the positive control, in MCF7 cells, which function as a model for a ER+
breast cancer tumor. (Wrobel and Gregoraszczuk 2014). MP induced the longest response
in MCF7 cells with increasing protein expression at 72 h, similar to estradiol stimulation,
which could be due to relatively low MP metabolism rates (Wrobel and Gregoraszczuk
2014). As for comparisons, MP increases the ERα protein expression in normal breast
epithelial cell line, MCF10A cells at 48 h, whereas both MP and PP had effects at 72 h
(Wrobel and Gregoraszczuk 2014). Moreover, the dependence of ER for the paraben's
effects was demonstrated by the co-treatment with ER inhibitor ICI 182,780 on MCF10A,
which attenuated the parabens effect. (Wrobel and Gregoraszczuk 2014).
All three parabens increased ERβ protein in MCF7 cells at 48 h and only MP at 72 h
(Wrobel and Gregoraszczuk 2014). In contrast, all three parabens increased ERβ protein
(ESR2 product) expression after 72 h treatment, but had no effects after 48 h, in MCF10A
cells (Wrobel and Gregoraszczuk 2014). ICI 182,780 treatments seemed to have no effect
on MCF10A cells (Wrobel and Gregoraszczuk 2014).

2.4.2. Progesterone Receptor
Progesterone receptor is another major receptor marker for patients being diagnosed with
breast cancer (Harbeck, Penault-Llorca et al. 2019). Similar to that of estrogen,
progesterone is a steroid hormone that influences the reproductive system and breast
development, and PR functions to regulate transcription and cell proliferation (Cenciarini
and Proietti 2019). PR mRNA expression is significantly increased by PP and BP after 24
h treatments in both MCF7 and MCF10A cells (Wrobel and Gregoraszczuk 2014).
Interestingly, however, MP and PP, but not BP, increased protein expression of PR in
MCF7 cells, but not MCF10A cells (Wrobel and Gregoraszczuk 2014). (Wrobel and
Gregoraszczuk 2014). Similarly, in vivo, MP and EP at 20, but not 4 mg/kg/day, induced a
significant increase of PR mRNA expression in SD rats' uterine tissue (Sun, Yu et al. 2016).
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2.4.3. Human Epidermal Growth Factor Receptor
Parabens have been demonstrated to crosstalk with HER2 to promote oncogenic c-myc
gene expression and proliferation of an ERα- and HER2-positive human BT-474 breast
cancer cells in an ERα dependent manner (Pan, Yuan et al. 2016). HER is a family of
transmembrane proteins that act as receptor tyrosine kinases PI3K/Akt signaling (Pan,
Yuan et al. 2016). Activation of PI3K/Akt can lead to the phosphorylation of ERα, which
enhances the affinity for binding of ER. Adding to the complexity, ERα has the ability to
crosstalk with HER signaling, but the synergy is greatly dependent on the presence of ERα
(Pan, Yuan et al. 2016).

Akt activation via HER has the ability to affect c-myc expression. c-myc mRNA expression
was enhanced by HER2 agonist heregulin (HRG) upon co-treatment with PP and BP in the
BT-474 cells (Pan, Yuan et al. 2016). Interestingly, PP and BP at 10 µM without HRG
appeared to induce a 10-20 fold increase of c-myc mRNA expression. Blocking ERα
activation with an ER inhibitor, such as ICI 182,780, raloxifene, or tamoxifen, attenuated
the synergistic effect of HRG and BP on c-Myc protein expression (Pan, Yuan et al. 2016).
Moreover, HRG was demonstrated to lower the dose of BP required to promote the BT474 cell proliferation. Chromatin Immunoprecipitation (ChIP) assays further demonstrated
that BP and HRG synergistically recruit ERα transcription factors to the promoter region
of the c-myc gene enhancing cellular proliferation which is attenuated by ER antagonists.

2.4.4. Androgen and Glucocorticoid Receptor
Androgen is another steroid present in women and functions primarily as testosterone, a
precursor to estrogen. Glucocorticoids are steroid hormones that function to abrogate
inflammation decreasing immune activity, to regulate electrolyte balance, and to regulate
glucose metabolism (Kolsek, Gobec et al. 2015, Busada and Cidlowski 2017, Schiffer,
Barnard et al. 2019). It has been shown that paraben (at 50 µM, verified as non-toxic to the
cells) stimulated glucocorticoid receptor (GR) by activating mouse mammary tumor virus
(MMTV) reporter in the MDA-kb2 cells, which are MDA-MB-453 cells that stably express
MMTV luciferase reporter gene and high levels of GR and androgen receptor (Kolsek,
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Gobec et al. 2015). Moreover, MP and EP showed anti-androgenic activities while BP
showed androgenic activities by the MDA-kb2 MMTV reporter assay (Kolsek, Gobec et
al. 2015).

2.4.5. G-Protein Coupled Receptor
Parabens have also been suspected to function through other pathways that are nongenomic, which are more rapid. G-protein coupled estrogen receptor 1 (GPER1 or GPR30)
is associated with the plasma membrane and acts through protein-kinase cascades such as
ERK1/2 (Wrobel and Gregoraszczuk 2015). GPR30 mediated signaling regulates matrix
metalloproteinases (MMPs), which are enzymes that function in the rearrangement of the
microenvironment and involved in cancer metastasis. GPR30 is highly expressed in
cancerous breast epithelial cells and breast tumors, especially those from patients who are
resistant to ERα inhibitors, like tamoxifen (Ignatov, Ignatov et al. 2011). MP, PP, and BP
at 20 nM upregulated GPR30 mRNA expression greater than estradiol in MCF7 cells after
24 h and in MCF10A cells after 6 and 24 h (Wrobel and Gregoraszczuk 2015).
Additionally, MP and PP increased GPR30 protein expression after 48 h in both MCF7 and
MCF10A cells and after 72 h in MCF7 cells. Interestingly, only BP, but not MP or PP,
increased GPR30 protein levels at 72 h in MCF10A cells (Wrobel and Gregoraszczuk
2015). It is well known that estrogen-GPR30 signaling activates a rapid response through
the activation of ERK1/2 and cAMP/PKA. Whereas no tested parabens affected cAMP
levels in either cell line, PP and BP increased phosphorylation of ERK1/2 in MCF-7 cells,
whereas MP and BP, but not PP, increased phosphorylation of ERK1/2 in MCF-10A cells.
This activation GPR30/ERK1/2 signaling pathway by parabens demonstrates an additional
mechanism by which breast cancer cells proliferation and progression can be enhanced by
parabens.

2.5.

Parabens Effect on Breast Cancer Progression

The influence on breast cancer proliferation by parabens have been well-reviewed
previously (Darbre and Harvey 2014). However, recent publications confirm previous
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findings and elaborate on the mechanism by which parabens affect breast cancer initiation,
proliferation, and metastasis.

2.5.1. Mimic Estrogen in Inducing ER+ Breast Cancer Gene Expression
As parabens are estrogenic, it is beneficial to identify if parabens elicit the same genomic
response as estrogens. Not only does this confirm the estrogenic nature of parabens, but it
could also unveil novel gene targets for breast cancer treatment. Using a set of 120 estrogen
responsive genes, paraben (10 µM) induced expression profile was compared to that of
estrogen (17-estradiol or E2) used at 10 nM in MCF7 cells. Among MP, EP, PP, and BP,
significant correlations of expression profiles to that of E2 were observed for PP and BP
(R = 0.74 and 0.60, respectively), indicating estrogenic effects of parabens in a manner that
is dependent on alkyl chain length. PP and BP-induced expression profiles correlated
significantly with the effects of E2 in genes coding for enzymes, signaling, proliferation,
transcription, and transport, and others. However, profiles induced by PP and BP resembled
each other more than that of estrogen (Terasaka, Inoue et al. 2006).

To gain a full picture of how paraben regulates genes in comparison with that of E2 in
MCF7 cells, the expression profiles of 19881 genes in MCF7 cells following a 7-day
exposure to 5(10-4) M MP, 10-5 M n-BP and 10-8 M E2 were studied using the GEAm2ersham CodeLink 20 K human expression microarray system (Pugazhendhi, Sadler et
al. 2007). Venn diagram showed that 2963 genes were changed by ≥ 2 fold by one or more
treatment. Only 61 genes were induced and 198 genes were downregulated by all three
treatments. The majority of genes were regulated by only one or two of the treatments,
indicating that significant differences in MCF7 cells’ response to paraben and E2. For
example, MP and BP upregulates interleukin 17 receptor B (IL17RB), otoferlin (OTOF),
and prolactin receptor (PRLR), but suppresses ubiquitin D and adrenomedullin, similar to
E2 (Pugazhendhi, Sadler et al. 2007). However, genes such as bruno-like5 RNA binding
protein (CELF5), myeloid/lymphoid mixed-lineage leukemia 2 transcription factor
(MLL2) and alanyl-tRNA synthetase like (AARSL) were upregulated more with paraben
treatments (Pugazhendhi, Sadler et al. 2007). Analyzing the global gene expression
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patterns demonstrated that even though some gene expression patterns are similar to E2,
the alterations do not match perfectly.

In addition to MCF7 cells, the estrogenic effects of pubertal exposure to 4 mg/kg bw/day
MP or EP in a uterotrophic assay similar to human exposure levels in immature SD rats
induced an upregulation of 138 genes and downregulation of 157 genes including estrogenresponsive genes in the uteri of the rats by quantitative real-time RT-PCR (Sun, Yu et al.
2016). mRNA expression of icabp, itmap, CaBD-9k, and PR were increased by both MP
and EP treatment (Sun, Yu et al. 2016). MP-induced globally upregulated genes include
those functioning in DNA replication and regulation of cell cycle such as E2F transcription
factor 1 (E2f1) (Gopalakrishnan, Teitelbaum et al. 2017). In contrast, MP globally
downregulated genes function in immune response and interferon signaling pathways,
including interferon regulatory factor (Irf7) (Gopalakrishnan, Teitelbaum et al. 2017).
Therefore, parabens can enhance DNA replication while also diminishing the immune
response setting the ideal conditions for proliferation.

Moreover, the effects of paraben on gene expression of select cell cycle/apoptosis genes
were compared with those of E2 in MCF7 and MCF-10A (Wrobel and Gregoraszczuk
2014). At mRNA levels, estradiol-induced G1/S phase genes (cyclin D1, D3 and cyclindependent kinase (CDK) 2 and 4), suppressed some cell cycle progression inhibitors and
also induced pro-survival genes (BCL2) in both cell lines. Parabens did not alter cyclins
expression, and MP and BP did not affect the select apoptotic genes in MCF-7 cells
(Wrobel and Gregoraszczuk 2014). However, parabens induced a greater response in MCF10A cells, were MP, PP, and BP all increased cyclin D1, E1, CDK 4, and CDK 2
expression, but suppress p21 expression (Wrobel and Gregoraszczuk 2014).

2.5.2. Induce Genome Instability
Genome instability refers to the genomic alterations cells acquire, leading to
carcinogenesis. Genome instability includes base-pair mutations, insertions, deletions, or
translocations of whole or fragmented chromosomes. These chromosomal aberrations
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hinge upon double-strand breaks (DSB) and often times occur in tandem with mutated
DNA repair genes, such as BRCA1 and BRCA2 (Duijf 2019).

The findings that parabens promote both MCF7 and MCF10A cell growth promoted the
study of genotoxicity studies by parabens. In vitro genotoxicity test and in vitro screening
cytokinesis-block micronucleus (CBMN) tests using human lymphoblastoid TK6, mouse
lymphoma L5178Y cells and human lymphocytes were performed (Finot, Kaddour et al.
2017, Guzel Bayulken, Ayaz Tuylu et al. 2019). The use of MCF-10A cells is to model the
effect of parabens on cells that are not cancerous, and parabens do increase the proliferation
of these cells at 100 nM. However, there has not been much insight into the genotoxic
effects of parabens on this cell type. EP, PP, and BP induce a genotoxic effect at high doses
(50-500 μg/mL) on lymphocytes, which is associated with worse clinical outcomes in
breast cancer patients (Finot, Kaddour et al. 2017, Guzel Bayulken, Ayaz Tuylu et al.
2019).

CBMN are miniature nuclei separate from the primary nucleus that contain desegregated
chromosomes where extensive DNA damage occurs and can subsequently be incorporated
back into the primary nucleus (Duijf 2019). L5178Y and TK6 cells had increased mutations
at the thymidine kinase (tk) locus upon high dose treatment of EP for 3 h indicative
resistance to apoptosis and inflicted a greater amount of CBMN at 120 μg/mL (Finot,
Kaddour et al. 2017). At 24 h, BP, PP, and isopropylparaben (IPP) all induced greater
numbers of CBMN at the highest dose of 100 μg/mL (Guzel Bayulken and Ayaz Tuylu
2019). With a 48 h exposure, PP and BP caused greater CBMN formation at 50 and 100
μg/mL (Guzel Bayulken and Ayaz Tuylu 2019). Shorter treatments were conducted in the
presence of S9, a metabolic activator, generating an unknown set of metabolites. TK6 cells
still had a significant CBMN presence after 26 h of treatment without S9, indicating EP’s
genotoxic effect is independent of S9 metabolic conversion (Finot, Kaddour et al. 2017).
Metabolite 4-hydroxybenzoic acid does not have the same CBMN formation effect as
parabens and only causes the formation of CBMN at 500 μg/mL for 48 h (Guzel Bayulken,
Ayaz Tuylu et al. 2019).
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Telomere shortening is one determinant to demonstrate parabens’ influence in
genotoxicity. A telomere is a nuclear protein that caps the chromosomes and prevents
degradation or DNA damage. Telomere shortening leads end-to-end joining of adjacent
chromosomes causing dicentric chromosomes. When these chromosomes undergo mitosis
DNA breaks occur promoting genome instability (Duijf, P. et al. 2019). EP causes a
decrease in fluorescence of telomere length in murine lymphoma cells (L5178Y) and
human lymphoma cells (TK6) cells as compared to their control cells (murine bone
marrow, human lymphoblastoid, and Burkitt lymphoma cells) using telomere staining and
comparing total fluorescence intensity of metaphase chromosomes (Finot, Kaddour et al.
2017). Loss of one telomere is the most significant disruption to telomere length upon EP
treatment (Finot, Kaddour et al. 2017). Additionally, when controlling for age, the telomere
length of paraben-exposed human lymphocytes was significantly shorter by both telomere
loss and deletions than the paraben-unexposed lymphocytes (Finot, Kaddour et al. 2017).
Therefore, parabens at higher doses (100-350 μg/mL) can affect telomere length.

As mentioned previously, the incorporation of DSB into the genome initiates
carcinogenesis if in a vulnerable DNA location (Kidane 2018, Jiang, Panda et al. 2019).
γH2AX and 53BP1 foci have been identified as markers of the formation of DSB if
localized to intra-chromosomal regions (Finot, Kaddour et al. 2017). Untreated L5178Y
and TK6 cells had these markers distributed throughout the nuclei, but EP treatment leads
to the localization of these foci at or near shortened or uncapped telomeres, indicating
telomere shortening (Finot, Kaddour et al. 2017). Even though there have been no
identifiable DSB, EP treatment of L5178Y cells demonstrated both clonal and sporadic
dicentric chromosomes (12 and 13) and trisomy chromosomes (15 and 18) (Finot, Kaddour
et al. 2017). EP treatment of TK6 cells has a greater amount of acentric chromosomes
(Finot, Kaddour et al. 2017). 4-Hydroxybenzoic acid at 250-500 μg/mL dosages and PP,
BP, and IBP at 50-100 μg/mL also led to the chromosomal aberrations, most commonly
chromatid breaks (Guzel Bayulken and Ayaz Tuylu 2019, Guzel Bayulken, Ayaz Tuylu et
al. 2019). Comet assay is the gold standard for analyzing DNA damage where the damaged
DNA fragments migrate through electrophoresis faster than the undamaged DNA
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developing a tail (Jiang, Panda et al. 2019). The length and intensity of the tail indicate the
number of DSB (Jiang, Panda et al. 2019). Lastly, a comet assay was conducted to
conclusively identify the presence of DSB in lymphocytes upon a 4-hydroxybenzoic acid
treatment, and only the highest concentration (1000 μg/mL) had significant DNA damage
compared to the solvent control (DMSO) (Guzel Bayulken, Ayaz Tuylu et al. 2019).
However, 100 μM BP appeared to show protective properties against genotoxicity, but not
cell proliferation induced by silver nanoparticles (Roszak, Domeradzka-Gajda et al. 2017).
Therefore, parabens have the ability to induce genotoxicity, but only at doses higher than
those from a typical environmental exposure; however, more studies at environmentally
achievable doses are necessary for a realistic perspective on parabens-induced
genotoxicity.

2.5.3. Evoke Breast Cancer Proliferation
Parabens at concentrations greater than 10 nM induce higher proliferation of cancerous
epithelial cells (MCF7) with attenuation by the inhibition of ERα and ERβ (Okubo,
Yokoyama et al. 2001, Lillo, Nichols et al. 2017). As mentioned previously, parabens and
their metabolite p-hydroxybenzoic acid bind to ER as compared to other environmental
phenols (Okubo, Yokoyama et al. 2001, Darbre, Byford et al. 2002, Pugazhendhi, Pope et
al. 2005). The potency of the paraben effect on proliferation and binding competition
correlated with their chain length and branching (Okubo, Yokoyama et al. 2001). Long,
branched parabens have more potency and have the greatest binding affinity and rank from
least to greatest as MP < EP < PP < IPP < BP and IBP. This affinity and potency ranking
was confirmed for IBP, benzP, and p-hydroxybenzoic acid by competitive binding assays
for ERα and ERβ (Okubo, Yokoyama et al. 2001, Darbre, Byford et al. 2002, Darbre,
Byford et al. 2003, Pugazhendhi, Pope et al. 2005).

Parabens also have the ability to enhance cellular proliferation in MCF10A cells,
implicating parabens’ effects on breast carcinogenesis (Khanna and Darbre 2013, Darbre
and Harvey 2014). Butylparaben at 0.5 mM MP, 50 μM PP, and 50 μM produced greater
number and size of cell colonies and MP and PP induced significantly greater colony
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formations (Khanna and Darbre 2013, Darbre and Harvey 2014). PP and BP maximum
colony formation peaked at 5 μM; however, MP had twice this maximum at 0.5 mM,
demonstrating that MP has the greatest effect on MCF10A cell growth (Khanna and Darbre
2013).

In vivo, MP significantly increases tumor growth of MCF-7 cells and patient-derived
xenograft (PDX) breast tumor in immunocompromised female mice in comparison with
the estrogen treatment (Lillo, Nichols et al. 2017). However, MDA-MB-231
mammospheres treated with 10 nM MP for 10 days did not induce proliferation nor
increase in tumor size, which confirmed previous reports of the non-prolific effect of
parabens on these cells (Lillo, Nichols et al. 2017). MDA-MB-231 cells are representative
of triple-negative breast cancer, which has no ER, PR, and HER2 expression, is the most
aggressive and is the most difficult to treat. Therefore, this suggests that parabens promote
both carcinogenesis and cancer proliferation in a hormone receptor-dependent manner at
low doses.

The mechanisms by which parabens promoted cell proliferation in normal or cancerous
breast epithelial cells have been explored. It was reported that the paraben activated
mitogenic ERK1/2 pathway through the activation of GPR30. PP and BP, but not MP, at
20 nM caused phosphorylation of ERK1/2 upon 5 to 120 minutes of exposure in MCF7
cells (Wrobel and Gregoraszczuk 2015). MP and BP, but not PP, at 20 nM also activated
ERK1/2 in MCF10A cells. The phosphorylation of Akt was induced by PP but was
significantly suppressed by BP in MCF7 cells (Wrobel and Gregoraszczuk 2015).

Moreover, another study suggested that parabens may enhance proliferation through
increasing aromatase (CYP19A1) expression. Aromatase functions in the conversion of
androgens to estrogen, which is a hormone that increases cellular proliferation of estrogen
responsive normal breast epithelial cells and breast cancer cells. Treatment of 20 nM MP
and PP caused a greater expression of CYP19A1 mRNA and protein expression in MCF7
cells; however, MP, PP, and BP decreased this expression in MCF10A cells below the
27

vehicle control (Wrobel and Gregoraszczuk 2013). Consistently, parabens also increased
the production of estradiol in MCF7 cells and decreased MCF-10A cells estradiol
production at a low concentration range (0.2 nM-200 nM) as compared to the high-dose (2
µM), which secreted less estradiol (Wrobel and Gregoraszczuk 2013).

2.6.

Parabens Effect on Breast Cancer Metastasis

The majority of diagnosed breast cancers are ER-positive and luminal A or B, which have
effective adjuvant pharmaceutical treatment (Gao and Swain 2018). Luminal A breast
cancers can be ER/PR+, HER2 negative and low levels of Ki67 (a marker of proliferation),
and Luminal B is defined as ER/PR+, HER2 +/- and high levels of Ki67 (Gao and Swain
2018). These cancerous epithelial cells can progress to mesenchymal-like cells typically
found in basal-like, hormone-resistant, and advanced breast cancers commonly known as
triple-negative breast cancer, the most deadly form of breast cancer. This process of
dedifferentiation is called epithelial-to-mesenchymal transition (EMT) and also occurs in
embryogenesis and wound healing (Macias and Hinck 2012, Lamouille, Xu et al. 2014).
The phenotypical alterations demonstrating EMT include anchorage independence,
polarization, migration, and invasion (Lamouille, Xu et al. 2014, Huang, Li et al. 2015).
Once cells have undergone EMT, they are able to function as mesenchymal cells and more
able to migrate through the basement membrane and into circulation leading to metastasis.

2.6.1. Cell-Surface Transformation
To begin the process of metastasis, the cancerous cells lose the expression of basement
membrane attachment cell-cell contact proteins, such as E-cadherin and vimentin,
characteristic of epithelial cells. Mesenchymal markers, such as fibronectin and N-cadherin
begin to be expressed leading to alterations in the extracellular matrix. The shift of Ecadherin to N-cadherin is linked with loss of cell-cell interaction and ultimately poor
clinical outcomes (Lamouille, Xu et al. 2014, Huang, Li et al. 2015). MCF7 cells exposed
to parabens showed the significant invasion of Matrigel and reduced the protein expression
of E-cadherin and β-catenin with multiple treatments, indicative EMT (Darbre and Harvey
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2014, Khanna, Dash et al. 2014). The mechanisms by which parabens reduced E-cadherin
expression have not been elucidated.

2.6.2. Stem Cell Markers
EMT can also be confirmed by examining the markers of stem cells which indicate the
dedifferentiation of cancerous cells to the mesenchymal state. A physiological level of MP
(4.4 μg per day) caused an increase of tumor size from MCF-7 xenografts and ER+ PDX
tumors. MP induced a shift to mesenchymal by upregulating mRNA expression of Nanog,
Oct4, and ALDH1 in both MCF7 and PDX mammospheres (Lillo, Nichols et al. 2017).
Interestingly, the pre-treatment of MCF7 cells with ER antagonist tamoxifen, a common
therapy for ER (+) breast cancers, does not impede the MP induction of mammosphere size
or NANOG protein expression (Lillo, Nichols et al. 2017). Therefore, it is likely that MP
impacted mammosphere formation and NANOG protein expression through ERindependent signaling pathways signaling.

2.6.3. Cellular Migration and Invasion
Disruption of tight junctions between the cells allows for tumor progression and metastasis,
cellular migration and invasion (Lamouille, Xu et al. 2014). These structural changes
induce stress and the formation of stress fibers, which provide structural strength to the
malformed cell. A migratory property allows the cancerous cells to traverse the
extracellular matrix for proliferation and nutrient acquisition. Once cells develop an
invasive characteristic, they progress to intravasation where the cells are able to pass
through the basement membrane and to survive in circulation (Semenza 2016).

It has been reported that 50 µM BP induced matrix degradation and invasion of MCF7 in
a 7-day treatment, whereas 0.5 mM MP, 50 µM PP and 50 µM BP promoted MCF7 cell
migration and invasion in 20 weeks of treatment (Darbre and Harvey 2014, Khanna, Dash
et al. 2014). Migratory effects by parabens also were demonstrated in other two estrogenresponsive human breast cancer cells T-47-D and ZR-75-1 cells (Khanna, Dash et al.
2014).
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2.7.

Conclusion

Humans are exposed to parabens throughout life from personal care products, food,
pharmaceuticals, industrialization, etc., and these parabens can be absorbed into
circulation. Parabens can negatively affect many different hormone and endocrine-related
processes. Specifically, parabens can influence breast cancer progression by binding and
activating ERs and modulating the expression of ERs and other steroid-related receptors,
such as PR, AR, and GPR30. Consequently, parabens can activate various signaling
pathways ultimately leading to breast epithelial cell proliferation. Moreover, parabens have
also been shown to encompass the ability to induce EMT, increase cell migration and
invasion, characteristics critical for breast cancer metastasis. However, many of the studies
tested parabens at very high doses, such as 50 μM. Therefore, further research is necessary
to understand the full extent of parabens toxic effects at environmental achievable doses.
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CHAPTER 3 :
PARABENS INDUCE INFLAMMATION IN STROMAL
FIBROBLASTS LEADING TO BREAST CANCER CELL
PROLIFERATION
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3.1.

Abstract

Background: It is increasingly realized that breast stroma plays a critical role in breast
carcinogenesis and breast cancer progression. Understanding the alterations that occur in
the stromal cells in breast carcinogenesis can lead to novel and effective therapeutic or
preventative strategies. Parabens are a group of 4-hydroxybenzoic acid esters, commonly
found in pharmaceuticals, food, personal care products, and paper as anti-microbial agents.
Studies have shown that parabens are estrogenic, act as endocrine disrupting chemicals in
experimental animals, and can accumulate in higher amounts in the breast cancer samples.
Therefore, we hypothesize that parabens may promote breast carcinogenesis by negatively
modulating breast stroma nearby breast epithelial cells.

Methods: 3T3-L1 murine and BRF human fibroblasts were exposed to the three most
common parabens, methyl-, propyl-, and butylparaben (MP, PP, and BP) at
environmentally relevant doses (0.02, 0.1, and 1 µM) for 6, 12, and 24 hours. Gene
expression was determined by RT-PCR. 3T3-L1 CARΔ1 cells, which are engineered to
express adenovirus receptors, were employed to study NF-κB activation followed by
Western analysis of p-p65 and IκBα degradation, two critical events for NF-B signaling
pathways. Lastly, paraben-treated fibroblast conditioned media was tested for their abilities
to promote the proliferation of autobioluminescent MCF7 breast cancer cells.

Results: A single exposure to all three parabens at the tested doses induced inflammatory
gene IL-1β, MMP9, COX2, and CYP19A1 in both murine 3T3-L1 fibroblasts and human
BRF cells. Consistently, all three parabens activate NF-B in both 3T3-L1 and BRF cells
as demonstrated by the activation of NF-B reporter and phosphorylation of p65 and IBα
degradation. Moreover, the conditioned media from paraben-treated 3T3-L1 fibroblasts
and human BRF cells induced proliferation of breast cancer MCF7 cells.

Conclusion: Parabens may play important roles in breast cancer progression by inducing
inflammation in breast stromal fibroblasts.
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3.2.

Introduction

Breast cancer remains the second leading cause of cancer mortality in women within the
US behind lung and bronchial cancers (ACS 2017). The tumor microenvironment or stroma
impacts breast cancer progression by enabling proliferative signaling, activating
angiogenesis, allowing invasion and metastasis via extracellular matrix (ECM)
remodeling, etc. through the communication of secreted chemokines and cytokines
(Hanahan 2011). Tumor stroma is composed of a variety of cell types, including
adipocytes, fibroblasts, macrophage, neutrophils, mast cells, and endothelial cell, all of
which cross-talk with each other and with nearby breast epithelial cells to promote
carcinogenesis and cancer progression (Soysal, Tzankov et al. 2015, Lee, Lee et al. 2018).

Chronic inflammation has been recognized for its association with an increased risk of
cancer development. Stromal inflammation is thought to activate dormant tumors or initiate
tumorigenesis in transplanted primary epithelial cells, a process called stromal induction
(Radisky and Radisky 2007). The stroma is densely populated with fibroblasts, and these
fibroblasts can enable tumor proliferation, sustain elevated pro-inflammatory gene
expression, accommodate metastasis, etc. (Lim and Moon 2016). Fibroblasts are typically
activated by wound healing or tissue injury, where they begin to play a role in inflammation
in the recruitment of immune cells to repair the damage (Kalluri 2016). A tumor comprises
a similar response to that of tissue damage or an injury with the activation of stromal
fibroblasts that release inflammatory cytokines for healing (Kalluri 2016). However, the
stroma consists of many other different cell types, including adipocytes, macrophage, mast
cells, endothelial cells, etc., and each cell type begins secreting different factors into the
stroma which are all able to have autocrine or paracrine action (Semenza 2016). Somehow,
the communication between these cells begins to permit the growth of cancerous cells and
begin to work in collaboration with cancer. Therefore, it is critically important to
understand the complex interactions between these stromal cells and the epithelial cells.

The inflammatory response by fibroblasts is critical in the communication with the
cancerous epithelial cells (Lim and Moon 2016, Balachander, Talukdar et al. 2018).
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Cyclooxygenase-2 (COX2) has been implicated in the development of various cancers,
including gastric, breast, lung, esophageal, and colon cancer (Li, Zheng et al. 2016, Sano,
Kogashiwa et al. 2018). COX2 is overexpressed in aggressive breast tumors associated
with poor prognosis and survivability, and knockout of COX2 in MCF7 breast cancer
epithelial cells attenuates proliferation (Denkert, Winzer et al. 2004, Brown, Subbaramaiah
et al. 2008, Han, Yang et al. 2014). Prostaglandin E2 (PGE2), a downstream product of
COX2, enhances tumor growth through inflammation, leading to angiogenesis,
invasiveness, and evading cell death (Li, Shan et al. 2015). Interleukin-1 beta (IL1β), one
prominent cytokine released into the inflamed stroma, has been shown to increase
invasiveness and metastasis of breast tumors and correlates with worse prognosis (Brown
2014, Stender, Nwachukwu et al. 2017). Additionally, IL1β contributes to endocrine and
chemotherapy resistance in ER+ breast cancers through activation of IKKβ, upstream of
NF-κB signaling (Stender, Nwachukwu et al. 2017).

Moreover, proteases within the stroma have been recognized as influential in the growth
of tumors. Matrix metalloproteinases (MMP) are enzymes that breakdown the ECM,
providing space for tumor growth, passages for invasion and metastasis, and are
overexpressed in many breast cancers (Zaremba-Czogalla, Hryniewicz-Jankowska et al.
2018). MMP-9 functions in digestion of ECM proteins, including collagen, fibronectin,
and laminin; in addition, MMP-9 can also degrade other non-matrix signaling proteins
within the stroma (Radisky and Radisky 2007). Interestingly, MMP-9 is a target of NF-κB
activation and is associated with COX2 activity via PGE2 production (Li 2012, ChimalRamirez, Espinoza-Sanchez et al. 2013).

It is well recognized that environmental exposures contribute to the development of many
chronic diseases, including cancer (Cui, Balshaw et al. 2016). Endocrine disrupting
chemicals (EDC) are industrial chemicals utilized to enhance product sustainability and
extend shelf-life but have been identified to dysregulate endocrine systems, causing
adverse health outcomes (Darbre 2006, Burks, Pashos et al. 2017). Parabens are alkyl esters
of p-hydroxybenzoic acid incorporated into personal care products, pharmaceuticals, food
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packaging, and paper products for their anti-microbial and anti-fungal properties. The most
common parabens used in the commercial products and therefore often being detected in
human biological samples are MP, PP, and BP (Figure 3.1.) (Giulivo, Lopez de Alda et al.
2016).

Even though parabens have been classified as weak EDCs, previous studies have
demonstrated their ability to bind hormone receptors at low-dose exposures, enhancement
of estrogenicity, and promotion of proliferation, invasion, and migration of breast epithelial
cells (Darbre and Harvey 2014). Moreover, total parabens have been detected within
normal breast tissue at an average concentration of 85 ng/g of tissue, indicating parabens
proximity to potentially cancerous epithelial cells (Barr, Metaxas et al. 2012). Furthermore,
parabens have been detected in higher amounts in breast cancer samples than their normal
breast tissue controls, ranging from 17.3 ng/g of tissue to 115 ng/g of tissue (Darbre,
Aljarrah et al. 2004). To this end, parabens have been shown to promote breast epithelial
cell growth; however, it is not clear whether parabens also negatively affect breast stroma
(Darbre and Harvey 2008).

The objective of this study was to investigate the inflammatory effects of common parabens
(MP, PP, and BP) at environmentally achievable doses (0.02, 0.1, and 1 µM) on the stromal
fibroblasts from both murine and human origins and the ability of exposed fibroblasts to
enhance breast cancer cell proliferation. We show that parabens induce the upregulation of
inflammatory genes (COX2 and IL1β), ECM remodeling gene MMP-9 and aromatase gene
CYP19A1 by activating the NF-κB signaling pathway. We further demonstrate the
conditioned media (CM) collected from paraben-exposed fibroblasts enhanced MCF7
breast cancer cell proliferation. Our study demonstrates that common paraben at
environmentally achievable doses promotes pro-inflammatory gene expression in the
fibroblasts of the stroma and leads to enhanced breast cancer proliferation.
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3.3.

Materials and Methods

3.3.1. Reagents
Dimethyl sulfoxide; methyl-, propyl-, and butylparaben were from Acros Organics (>99%,
Thermo Fisher Scientific, Pittsburg, PA). Caffeic acid phenethyl ester (CAPE) was ordered
from Tocris Bioscience (Minneapolis, MN). Ultra-pure lipopolysaccharide (LPS) was from
List Biological Laboratories (Campbell, CA). Phospho-NF-κB p65 (Ser536) (no. 3033)
and NF-κB -p65 (D14E12) XP (no. 8242) were purchased from Cell Signaling Technology.
IκBα (C-21) (sc-371) was purchased from Santa Cruz Biotechnology. Anti-β-actin (AC15) (no. A1978) was from Sigma-Aldrich. Neomycin (G-418) was purchased from
Research Products Incorporated (Mount Prospect, IL).

3.3.2. Cell Culture
Murine 3T3-L1 fibroblasts (ATCC, Manassas, VA) were grown in Dulbecco’s modified
Eagle’s medium (DMEM) containing 10% calf serum (HyClone).

Murine 3T3-L1

coxsackievirus and adenovirus receptor (CARΔ1) cells were a gift from Dr. Orlicky
(Orlicky DJ 2001) and were grown in DMEM containing 10% fetal bovine serum (FBS)
(Atlanta Biological, Flowery Branch, GA). Human subcutaneous breast fat preadipocytes
(BRF) (Zenbio, NC) were grown in Preadipocyte Medium (PM-1) according to the
manufacturer’s instructions (Zenbio, NC). Human Autobioluminescent MCF7 cells were a
gift from Dr. Ripp ( 490 BioTech, Inc., Knoxville, TN) (Xu, Ripp et al. 2014) and were
grown in DMEM 10% FBS with G-418. All are grown in 5% CO2, 37oC conditions.

3.3.3. Immortalization of Primary BRF Cells
Immortalization of primary BRF cells was achieved by infecting the cells with lentivirus
encoding the SV40LT antigen. SV40LT antigen was first cloned into lentivirus expressing
vector carrying the neomycin phosphotransferase gene (Alwin Prem Anand, Gowri Sankar
et al. 2012). To generate lentivirus particles, SV40LT vector was co-transfected with
packaging (psPAX2) and envelope (pMD2.G) vectors (Addgene; Boston, MA) in
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HEK293T cells (GeneCopoeia, Inc; Rockville, MD) using FuGENE® HD transfection
reagent (Promega Corporation; Madison, WI) following manufacturer’s guidelines and
then used to infect BRF cells. Stable cell lines were selected using G-418 antibiotic (300
µg/ml) for two weeks.

3.3.4. Paraben Treatment
To detect the inflammatory effects of low-dose paraben on 3T3-L1 or BRF fibroblasts, a
single exposure

of 0.02, 0.10, or 1.0 μM methyl-, propyl-, or butylparaben was

administered in low-serum conditions, 0.25% calf serum (HyClone) for 3T3-L1 cells and
1% charcoal-stripped fetal bovine serum (CS-FBS) (HyClone) for BRF cells. DMSO and
LPS were used as vehicle control and positive control, respectively.

3.3.5. RNA and Quantitative Real-Time PCR
Total RNA was prepared from fibroblasts using TRIzol (Invitrogen Coorporation,
Carlsbad, CA) following the manufacturer’s protocol. Total RNA quantity was measured
using NanoDrop ND-1000 Spectrophotometer (NanoDrop Technologies, Wilmington,
DE). Reverse transcription was conducted utilizing High-Capacity cDNA Reverse
Transcription kit (Thermo Fisher Scientific) following the manufacturer’s protocol. mRNA
expression of fibroblast inflammation markers and housekeeping gene 36B4 (Table 1) were
measured quantitatively utilizing PowerUp SYBR Green Master Mix (Thermo Fisher
Scientific) and were analyzed in a 96-well template via an ABI 7300 HT Real-Time PCR
System with cycle conditions of 50oC 2 min, 95 oC 2 min, and 40 cycles of 95oC for
15s/60oC for 1 min. The relative gene expression was calculated utilizing a 2(-ΔΔCt) method
and normalized against 36B4.

3.3.6. Reporter Gene Assays
3T3-L1 CARΔ1 and BRF fibroblasts were seeded in a 24-well plate format and infected
with adenovirus encoding NF-κB-Luc reporter gene and adenovirus encoding β42

galactosidase (β-gal) control plasmid for 15 h, as described previously (Purohit, Hu et al.
2013). The cells were probed with various parabens for 12 h. The cell lysate was prepared
utilizing Reporter Lysis 5X Buffer (Promega). Reporter luciferase activity was measured
using GloMax Luminometer (Promega, Madison, WI) and normalized by β-gal expression.

3.3.7. Western Blot Analysis
Total cell lysates were prepared and protein concentrations measured by Pierce BCA
protein assay kit (Thermo Fisher Scientific). 20-40 μg of total cell lysate were run through
a polyacrylamide gel and transferred to polyvinylidene difluoride membrane (Bio-Rad).
The membrane was blocked in 20 mM Tris-HCl, 137 mM NaCl, and 0.1% Tween 20 (pH
7.4) containing 5% nonfat milk or 5% bovine serum albumin (BSA). The membrane was
immunoblotted with primary antibodies at 4 oC overnight followed by secondary antibody
conjugated with horseradish peroxidase. The signal was detected utilizing SuperSignal
West Pico PLUS Chemiluminescent Substrate (Thermo Scientific), HyBlot CL
autoradiography film (Denville Scientific), and a Konica SRX-101A film processor.
Quantification by densitometry was conducted using ImageJ software.

3.3.8. Conditioned Media Collection
3T3-L1 and BRF fibroblasts were seeded into 60 mm dishes. Each plate of cells was treated
with MP, PP, BP (each at 1 µM) or controls (DMSO or LPS) in 5% CS-FBS. After 72 h or
10 days, the treatment media was removed, and the cells were washed twice with phenolred free (PRF) media (HyClone) to remove residual parabens. To collect CM, cells were
then cultured for 48 h in PRF media with 5% CS-FBS and penicillin and streptomycin.
After 48 h, the media was collected and centrifuged at 600 rpm for 5 minutes. The
supernatant was transferred into a fresh tube and stored at 4 oC before use.
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3.3.9. Bioluminescent Imaging
Autobioluminescent MCF7 cells were plated at 30% confluency in quadruplicate wells of
a 24-well opaque, clear bottom plate (Labnet/Corning Inc., Cary, NC). After attachment
overnight, MCF7 cells were washed with PRF media and treated with CM: fresh media in
a 1:1 ratio. Treatment persisted for 7 days with changing CM at day 4. On day 7, plates
were transferred to CCD-based IVIS Lumina imaging system (PerkinElmer).
Autobioluminescent readings were acquired 3 times at 10 min intervals according to the
manufacturer’s instructions.

3.3.10. Statistical Analysis
All data are presented as means + SE. Measurements were performed in triplicates unless
otherwise indicated Statistical analysis was performed using SigmaPlot 14.0 (Systat
Software). One-way ANOVA on ranks or one-way ANOVA with repeated measures
followed by multiple comparison tests (Student-Newman-Keuls method) were used to
determine the differences between treatment groups or time points. Student’s t-tests were
conducted to evaluate LPS compared to the control. The level of significance was set at P
< 0.05. The effects of treatment and plate location on fold change of average radiance were
analyzed using two-way ANOVA analysis for each time point in 3T3-L1 and human
BRF fibroblasts.Post hoc multiple comparisons were performed with Tukey’s adjustment.
Statistical significance was identified at the level of 0.05. Analyses were conducted in SAS
9.4 TS1M4 for Windows 64x (SAS institute Inc., Cary, NC).

3.4.

Results

3.4.1. Parabens Induce mRNA Expression of Inflammatory Genes and CYP19A1 in
Murine and Human BRF Fibroblasts
3T3-L1 fibroblasts were exposed to MP, PP, or BP or their vehicle control (DMSO) at
0.02, 0.1, or 1 µM for 6, 12, or 24 h. LPS was included as a positive control. The
inflammatory response to parabens differs depending on the length of the side chain, dose,
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and time of exposure. All three tested parabens significantly upregulated inflammatory Il1β
mRNA expression in 3T3-L1 fibroblasts. Compared to DMSO, 0.1 µM MP increased the
maximal 2.5 fold of Il1β mRNA expression at 6 h (p<0.05) but had minimal effects at 12
or 24 h of exposure (Figure 3.2.A), where 0.1 µM PP increased ~ 2 fold of Il1β mRNA
expression at 6 h (p<0.05), increased to ~ 3 fold at 12 h and maintained at 1.5 fold at 24 h
(p<0.001) of exposure (Figure 3.2.A). Butylparaben increased greater than 5 fold Il1β
mRNA expression at 0.1 and 1 µM at 6 h. The increased levels were maintained at 12 h,
but dropped at 24 h by 0.1 µM whereas gradually increased and reached the maximal 12
fold at 24 h of exposure by 1 µM (p<0.05) (Figure 3.2.A). In contrast, the maximal 7 fold
Il1β mRNA level by LPS was observed at 12 h and decreased to 3.5 fold at 24 h of exposure
(Figure 3.2.A).
In addition to Il1β, we also examined Mmp-9 mRNA expression, a key MMP in matrix
remodeling in breast cancer growth. Even though LPS significantly upregulated Mmp-9
mRNA expression at 6, 12, and 24 h exposure, there is not as great of an influence by
parabens except that MP increased 1.5 fold at 6 h by 0.1 µM and PP increased 1.5 fold at
12 h by 1 µM compared to the vehicle control (Figure 3.2.B). Butylparaben had increased
Mmp-9 expression 2 fold at 6 h by both 0.1 and 1 µM (p<0.01). We examined the effects
of parabens on Cox2 mRNA expression in fibroblasts as COX2 upregulation is greatly
associated with the progression of many cancers, including breast cancer. All three paraben
significantly upregulated Cox2 mRNA expression at 24 h (p<0.05) with BP reaching a
maximum of 4.5 fold at 1 µM (p<0.05) compared to the control. In contrast, LPS increased
1.8 fold of Cox2 mRNA expression at 12 h and maintained the level at 24 h (p<0.05)
(Figure 3.2.C).

Lastly, we analyzed mRNA expression of Cyp19a1, the enzyme responsible for the
conversion of androstenedione and estrone to estrogen (Gerard and Brown 2018). All
parabens tested, PP and BP in particular, significantly upregulated Cyp19a1 mRNA
expression. MP at 0.1 µM significantly induced at 6 h (p<0.05). PP at concentrations
greater than 0.1 µM significantly induced Cyp19a1 mRNA at all tested time points
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(p<0.01), and induced significant upregulation by all tested concentrations at 24 h (p<0.05).
All BP concentrations significantly upregulated Cyp19a1 mRNA expression at 6 h
(p<0.05), and 12 h. At 24 h, BP greater than 0.1 µM concentrations increase expression
(p<0.01) with maximal expression of 13 fold 1 µM compared to the vehicle control. In
contrast, LPS only increased ~ 2-3 fold of Cyp19a1 mRNA expression at 12 and 24 h
exposure (p<0.001) (Figure 3.2.D).

Similarly to murine fibroblasts, immortalized BRF also responded to all three tested
parabens, depending on the length of the side chain, dose, and time of exposure (Figure
3.3.). MP induced maximal ~ 2 fold of IL1β mRNA expression at 12 h at 0.1 and 1 µM
(p<0.05) and had no effects at 24 h in human immortalized BRF fibroblasts (Figure 3.3.A).
Interestingly, low doses (0.02 and 0.1 µM), but not a high dose (1 µM), of PP induced ~ 2
fold of IL1β mRNA at 6 h (p<0.01) and had lesser effects at 12 or 24 h of exposure (Figure
3.3.A). However, at 24 h high dose PP induced the greatest response (p<0.01).
Butylparaben only induced ~ 1.6 fold of Il1β mRNA at 12 h at the low dose of 0.02 µM
(p<0.05) (Figure 3.3.A). In contrast, LPS induced a maximal 3.5 fold of Il1β mRNA
expression at 12 h and a lesser fold increase at 24 h (Figure 3.3.A).

In contrast, all three parabens induced more robust responses of MMP-9 in human BRF
cells. Compared to the DMSO, MP induced ~ 2.5 fold of MMP-9 mRNA expression at 6 h
by 0.02 µM and ~ 4 fold by 0.10 µM (p<0.05), reaching 5 fold at 12 h at 0.1 µM. At 1 µM,
MP induced ~ 4 fold of MMP-9 mRNA expression at 12 h and maintained the level at 24
h (Figure 3.3.B). Propylparaben dose-dependently increased MMP-9 mRNA, reaching 4.5
fold at 1 µM, at 6 h (p<0.05). This dose-dependent response subsided at 12 and 24 h.
Butylparaben had an inverse dose-dependent response with 0.02 µM increasing gene
expression the most (p<0.01) at 6 h. Low dose BP maintained the most significant response
at 12 h, but this enhancement subsided by 24 h. LPS only induced a minimal response of
MMP-9 in human BRF cells (Figure 3.3.B).
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Propyl- and butylparaben also significantly induced COX2 mRNA expression (Figure
3.3.C). MP induced ~1.5 fold of COX2 mRNA expression at 0.02 µM at 6 h (p<0.01) and
induced similar increases at 0.1 and 1 µM at 12 h (Figure 3.3.C). PP induced a maximal
2.5 fold of COX2 mRNA at lower doses of 0.02 (p<0.05) and 0.1 µM (p<0.01) at 6 h, which
were not maintained at 12 and 24 h. At 1 µM, PP induced a maximal 2.3 fold at 24 h
(p<0.05) (Figure 3.3.C). BP induced a ~ 2.3 fold of COX2 mRNA at 1 µM at 6 h and 24 h
(p<0.05). BP also induced a maximal of 2 fold at 0.02 µM at 24 h (p<0.01). In comparison,
LPS induced a modest increase of COX2 mRNA at 6 h and reached the maximal 2 fold at
24 h in human BRF cells (p<0.05) (Figure 3.3.C).

Lastly, CYP19A1 mRNA expression was significantly upregulated by all three tested
parabens at 6 h. However, at 12 h only MP induced significant upregulation and PP at 24
h (p<0.05). Propylparaben increased CYP1A1 to ~ 2 fold at 0.1 µM at 12 h compared to
the DMSO (p<0.05). Propylparaben induced most significant response with a ~ 12 fold
increase at 0.02 µM at 6 h (p<0.05). All doses of BP increased CYP19A1 mRNA expression
at 6 h with 0.1 µM reaching ~ 10 fold (p<0.05). Similarly, LPS induced a ~ 2 fold increase
of CYP19A1 mRNA expression at 6 h which subsided over 12 and 24 h in human BRF
fibroblasts (Figure 3.3.D).

3.4.2. Parabens Activate NF-κB Signaling in Murine and Human Fibroblasts
Next, we investigated the effects of paraben on the NF-κB signaling pathway, which is
critical signaling that drives inflammatory gene expression (Li and Verma 2002). First, we
investigated NF-κB activation using NF-κB-responsive luciferase reporter assays where
fibroblasts were transiently infected with adenovirus encoding an NF-κB-Luc receptor. At
1 µM, all three parabens activated NF-κB in 3T3-L1 cells with increasing potency,
correlating with the length of the linear alkyl chain (MP < PP  BP) (Figure 3.4.A, left
panel). To confirm the findings of the reporter assays, we also tested LPS activation with
or without pre-treatment of an NF-κB inhibitor CAPE. LPS induced ~3 fold of NF-κB
activation, which was significantly attenuated by CAPE (Figure 3.4.A, right panel). Similar
to the gene expression results, MP and PP induced significant NF-κB activation in human
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BRF fibroblasts at a lower dose of 0.02 µM (p<0.05 for MP and p<0.05 for PP), compared
to murine 3T3-L1 cells (Figure 3.4.B). In contrast, LPS induced 3.5 fold of NF-κB
activation (p<0.01) in human BRF fibroblasts.
We further confirmed paraben-induced NF-κB activation in 3T3-L1 fibroblasts by
analyzing the phosphorylation of p65 and degradation of IκBα, two key events leading to
NF-κB activation (Li and Verma 2002) with treatment of DMSO (Figure 3.5.A), 1 μM BP
(Figure 3.5.B), or LPS (Figure 3.5.C) in a time-dependent manner. Quantification
comparing 1 μM BP to its own time 0 shows the degradation of IκBα (Figure 3.5.D) and
phosphorylation of p65 (Figure 3.5.E). At 15 minutes, 1 µM BP significantly degraded
IκBα compared to the zero time point (p<0.001) and p65 phosphorylation was enhanced at
30 minutes (p<0.001). When normalizing the BP NF-B activation to the associated
DMSO, similar trends in IκBα and p-p65 protein expression occurred with degradation
beginning at 15 minute and phosphorylation at 30 minutes (Figure 3.5.F). Moreover,
paraben induced NF-κB activation as measured by these two events in the BRF cells with
treatment of DMSO (Figure 3.6.A), 1 μM MP (Figure 3.6.B), or LPS (Figure 3.6.C) in a
time-dependent manner. Quantification of IκBα degradation showed LPS induced NF-B
activation within 5 minutes of treatment, and 1 μM MP induced NF-B activation at 30
minutes (Figure 3.6.D), similar to the murine response. Additionally, phosphorylation of
p65 quantification demonstrates a drastic NF-B activation by LPS beginning at 15
minutes and minimal response to 1 μM MP beginning at 5 minutes in human BRF
fibroblasts (Figure 3.6.E). When normalizing MP NF-B activation with DMSO, a change
in degradation profile occurred, but IκBα still degraded at 30 minutes and p65 had greatest
phosphorylation at 90 minutes (Figure 3.7.F).

3.4.3. Conditioned Media from Parabens-Treated Fibroblasts Regulates Breast Cancer
Cell Proliferation
To explore the effects of paraben exposure on stromal induction and cancer progression,
we evaluated the effects of the conditioned media (CM) collected from paraben-treated
fibroblasts on the proliferation of human breast cancer MCF7 cells. We evaluated CM
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collected after short-term (72 h) and long-term (10 day) exposure of parabens on both 3T3L1 and BRF fibroblasts. The CM was then used to induce the proliferation of
autobioluminescent MCF7 cells without the presence of paraben. At 72 h of paraben
exposure to 3T3-L1 cells, MP induced greater proliferation of MCF7 cells compared to
that of the other parabens; however, parabens elicit less MCF7 proliferation than the
vehicle control (DMSO) (Figure 3.7.A). However, CM from 10-days exposure to PP led
to significantly increased proliferation of MCF7 cell (p < 0.01) compared to DMSO (Figure
3.7.B). Interestingly, MCF7 cells have significantly increased proliferation after exposure
to the CM collected from 72 h exposure to all three parabens in human BRF fibroblast (p
< 0.001) (Figure 3.7.C). None of the CM from 10 days exposure in human BRF cells
significantly induced MCF proliferation compared to DMSO, although the CM from BP
induced more proliferation than that from MP, but not PP(p<0.01) (Figure 3.7.D).

3.5.

Discussion and Conclusion

To our knowledge, our study is the first study that demonstrates parabens at environmental
achievable doses activate the NF-κB signaling pathway and induce inflammatory gene
expression in both murine and human stromal fibroblasts derived from breast fat. Using
conditioned media, we demonstrate that the inflammatory response stimulated by low-dose
parabens in stromal fibroblasts promotes breast cancer cell growth. Our results, therefore,
suggest that typical exposure to parabens from the environment can elicit a proinflammatory response in the breast stromal fibroblasts, which then stimulate nearby
cancerous breast epithelial cells to proliferate.

Parabens are ubiquitously present in the environment due to their properties as an antimicrobial chemical and their preservative nature. These EDCs are absorbed dermally or
ingested daily from a variety of different sources, including personal care products such as
lotions, cosmetics, deodorants, and hair products; pharmaceuticals; food; etc. (Darbre and
Harvey 2014). Once absorbed, parabens are distributed throughout the body and have been
detected intact in blood, breast milk, placenta, and urine (Sandanger, Huber et al. 2011,
Kolatorova 2017, Shen, Liang et al. 2017). The intakes of parabens from food range from
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207-940 ng/kg body weight. However, absorption from personal care products ranges from
31-766 µg/kg body weight (Darbre and Harvey 2014). An individual is exposed to parabens
multiple times per day through every consumption or application of product containing the
chemical. Unconjugated parabens are present in human serum within 5 h of absorption,
and conjugated parabens can remain in human serum for 24 h (Shin, Shin et al. 2019).
Therefore, we tested the effects of parabens at 6 h of exposure finding that they induce an
inflammatory response. Additionally, we found that the inflammatory response is sustained
as the fibroblasts are exposed to parabens for 12 and 24 h. Therefore, continual exposure
to parabens throughout a day maintaining a free paraben presence in the serum for 12 or
24 h can also lead to stromal inflammation.

Parabens have been implicated in a variety of different diseases, including obesity, fertility,
menstruation, and cancer (Hu, Chen et al. 2013, Smith, Souter et al. 2013, Darbre and
Harvey 2014, Nishihama, Yoshinaga et al. 2016). Many of these diseases could be a result
of parabens’ estrogenic properties, which have been well characterized (Lange, Kuch et al.
2014). More specifically, parabens utilize a variety of signaling pathways to elicit these
estrogenic effects including ERK1/2 and Akt signaling associated with ERα, ERβ, HER,
GR, and other receptors (Wrobel and Gregoraszczuk 2014, Sun, Yu et al. 2016) (Kolsek,
Gobec et al. 2015, Wrobel and Gregoraszczuk 2015, Pan, Yuan et al. 2016). Through these
pathways, parabens have been reported to directly promote breast cancer cell proliferation,
mammosphere formation, epithelial to mesenchymal transitions, and metastasis (Khanna
and Darbre 2013, Darbre and Harvey 2014, Khanna, Dash et al. 2014, Lillo, Nichols et al.
2017).

As it is well recognized that breast cancer survival requires cooperation between breast
cancer cells and the surrounding stroma (Hanahan 2011). Our findings add to the current
literature by demonstrating parabens’ abilities to induce an inflammatory response in
stromal fibroblasts, leading to a toxic microenvironment that can stimulate breast cancer
cell growth. The inflamed stroma is thought to play critical roles in the breast cancer
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development as it is shown that the tumor cells cannot survive if a tumor is removed from
inflammation translocated to a normal stroma (Bussard, Mutkus et al. 2016).

The stroma is composed of a variety of different cell types, including fibroblasts,
adipocytes, immune cells, endothelial cells, etc.; each plays different roles in tissue
homeostasis (Bussard, Mutkus et al. 2016). Stromal fibroblasts are the most abundant cell
type in the stroma and are versatile as they act as precursors to various mesenchymal cell
types, chondrocytes, adipocytes, myocytes, and endothelial cells (Kalluri 2016). These
cells are activated during the wound healing response as well as response in tissue damages
caused by tumors (Kalluri 2016, da Cunha, Domingos et al. 2019). Once activated,
fibroblasts begin to secrete growth factors, microRNAs, cytokines and chemokines among
other factors in both autocrine and paracrine fashion, leading to tumor-stromal cell and
stromal cell-stromal cell crosstalk resulting in cancer progression and epithelialmesenchymal transitions (da Cunha, Domingos et al. 2019). Additionally, fibroblasts
release of MMPs promoting the restructuring of the extracellular matrix proteins, including
collagens, hyaluronic acid, laminins and fibronectin enabling cancerous cells growth and
metastasis (da Cunha, Domingos et al. 2019). Therefore, the secretome contributions from
activated fibroblasts can function to promote cancer progression.

In this study, we have attempted to address the inflammatory effects of common parabens
at environmentally achievable doses on stromal fibroblasts and the subsequent ability of
exposed fibroblasts to enhance breast cancer cell proliferation. Our results indicate that
parabens at low concentrations upregulate the mRNA expression of Cox2, Il1β, and MMP9 dependent on the type, dose, and exposure time of parabens. In murine fibroblasts,
parabens enhanced the inflammatory response correlating with the increasing length of the
linear alkyl side-chain (MP < PP < BP), where BP consistently generated the most
significant response over time. In contrast, human fibroblasts' inflammatory response
correlates with the decreasing length of the linear alkyl side-chain (BP < PP < MP).
Methylparaben and PP provoke a higher fold and more sustainable inflammatory response
than that of BP in the human BRF cells. Interestingly, MP is the type of paraben most
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common in the environment and present in most abundance in the systemic fluids, making
it the greatest risk in inducing inflammation in human breast fibroblasts (Greige-Gerges,
Kaissi et al. 2013).

These results of increase mRNA expression of inflammatory markers are consistent with
the activation of NF-κB reporter and signaling pathways by paraben treatment. However,
we did not address the other signaling pathways that parabens are known to influence.
Some of the variability in gene expression patterns observed could be a result of activating
the intricate network of signaling pathways that lead to activation of NF-B. An NF-κB
signaling pathway is critical in mediating inflammatory response (da Cunha, Domingos et
al. 2019). Two critical downstream events that lead to NF-B activation are IBα
degradation and phosphorylation of p65 (Hayden and Ghosh 2004). The three markers
identified to be upregulated by paraben exposure are all connected to the NF-κB signaling
pathway (Li 2012, Kalluri 2016, Suman, Sharma et al. 2016, Tulotta and Ottewell 2018).
Together, our results suggest that selected parabens at environmental achievable doses
induced inflammatory gene expressions in both murine and human breast derived
fibroblasts, which is accompanied by activation of NF-B signaling pathways even though
we do not conclusively show parabens directly activate NF-B signaling. Future studies
are warranted to confirm these results by conducting in vitro studies and in vivo studies
using NF-κB knockdown or inhibitors to see if NF-B is required in paraben-induced
inflammatory effects .

Furthermore, we wanted to determine whether paraben stimulated inflammation in
fibroblasts is sufficient to stimulate the proliferation of breast cancer cells, which is
consistent with the impact of an inflamed stroma on carcinogenesis. Conditioned media
was collected after treating the fibroblasts with parabens and washing the fibroblasts to
remove any residual intact or hydrolyzed parabens, and used at a 1:1 ratio with the fresh
media and was applied on autobioluminescent MCF7 cells. From both murine and human
fibroblasts, paraben-stimulated conditioned media are sufficient to enhance the
proliferation of MCF7 cells without direct exposure of parabens to the breast cancer cells.
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At 1 µM, BP and PP, but not MP, significantly induced Il1β mRNA expression in 3T3-L1
fibroblasts; In contrast, MP and PP, not BP, significantly induced IL1β mRNA expression
in human BRF cells. As one prominent cytokine in the inflamed stroma, IL1β has been
shown to increase invasiveness and metastasis of breast tumors and correlates with worse
prognosis (Brown 2014, Stender, Nwachukwu et al. 2017). Additionally, IL1β is also
implicated in endocrine and chemotherapy resistance in ER+ breast cancers (Stender,
Nwachukwu et al. 2017). Whether IL1β in the conditioned media promoted MCF
proliferation remains to determined.

Upregulation of COX2 leads to the production of prostaglandins, such as PGE2 (Wang and
Dubois 2006). PGE2 promotes tumor growth by binding to it receptors EP1-4 and
activating signaling pathways that promote proliferation and inhibit apoptosis, such as RasMAPK pathway and EGFR/PI3K and Akt/ PPAR pathway (Wang and Dubois 2006). At
1 µM, all tested paraben significantly induced Cox2 mRNA expression in 3T3-L1
fibroblasts and BP and PP, but not MP significantly induced COX2 mRNA expression in
human BRF cells. It remains to be determined whether Cox2/PGE2 underlies the effects of
the conditioned media collected from paraben-exposed fibroblasts.

Moreover, at 1 µM all tested parabens significantly induced Cyp19a1 mRNA in 3T3-L1
fibroblasts and MP and BP, but PP, significantly induced CYP19A1 mRNA expression in
human BRF cells. It remains to be determined whether paraben significantly increases
estrogen production from exposed fibroblasts thereby increasing ER+ MCF7 cell
proliferation. Future studies are needed to determine the nature of the soluble factors that
drive MCF7 cell proliferation from paraben exposed fibroblasts.

The insight of paraben-induced inflamed fibroblasts enhancing breast cancer proliferation
is significant as women are exposed to these chemicals on a daily basis at low doses. As
we only demonstrate the increase of proliferation using a functional assay, additional
studies are needed to identify the critical soluble factors in the conditioned media from the
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fibroblasts and the molecular mechanisms by which these soluble factors from parabenexposed fibroblasts stimulate breast cancer cell proliferation.

In conclusion, we have shown that parabens, specifically MP, PP, and BP at environmental
achievable doses, induce the upregulation of IL1β, COX2, and MMP9 in both murine 3T3L1 and human BRF cells in vitro. The inflammatory responses induced by parabens are
accompanied by the activation of NF-κB signaling. Furthermore, we demonstrate that the
secretions collected from paraben-exposed fibroblasts are sufficient to enhance breast
cancer proliferation, suggesting that parabens at environmental achievable doses may
promote inflammation in the stroma thereby promoting breast cancer progression.
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Appendix

Methylparaben

Propylparaben

Butylparaben

.
Figure 3.1. Paraben chemical structures.
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A. Il1β

B. Mmp9

C. Cox2

D. Cyp19a1

Figure 3.2. Parabens induce inflammatory gene expression in 3T3-L1 fibroblasts.
3T3-L1 fibroblasts were treated with selected parabens (0.02, 0.10, 1.0 μM) for the
indicated time period. DMSO was the vehicle control and LPS was the positive control.
Relative mRNA expression of inflammatory markers (A. Il1β, B. Mmp9, and C. Cox2) was
analyzed. The relative mRNA expression was normalized to 36B4 and expressed as fold
of that of the DMSO sample. Data are mean + SE (n = 3). One-way ANOVA on Ranks
was performed followed by multiple comparison tests with Student Newman-Keuls
method to compare with the control. * - p < 0.05, ** - p < 0.01, and *** - p < 0.001.
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A. IL1β

B. MMP9

C. COX2

D. CYP19A1

Figure 3.3. Parabens induce inflammatory gene expression in human BRF
fibroblasts.
BRF fibroblasts were treated with selected parabens (0.02, 0.10, 1.0 μM) for the
indicated time period. DMSO was the vehicle control and LPS was the positive control.
Relative mRNA expression of inflammatory markers (A. Il1β, B. MMP-9, and C. Cox2)
was analyzed. The relative mRNA expression was normalized to 36B4 and expressed
as fold of that of the DMSO sample. Data are mean ± SE (n = 3). One-way ANOVA on
Ranks was performed followed by multiple comparison tests with Student NewmanKeuls method to compare with the control. * P < 0.05, ** P < 0.01, and *** P < 0.001.
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A. 3T3-L1

B. BRF

Figure 3.4. Parabens activate NFκB reporter in both murine and human fibroblasts.
A. 3T3-L1 and B. BRF fibroblasts were infected with adenovirus containing NFκB-Luc
and β-galactosidase (β-gal) for 15 hours and stimulated with 0.02, 0.1, or 1 μM MP, PP, or
BP along with appropriate controls for 12 hours. Reporter gene assays were conducted and
relative luciferase activity was normalized by β-gal for each sample and expressed as fold.
Data are means + SE (n=3). * P < 0.05, ** P < 0.01, and *** P < 0.001.
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A. DMSO

D. IκBα Degradation

B. BP (1μM)
E. p65 Phosphorylation

C. LPS

F. Normalized BP

Figure 3.5. Paraben activates NFκB signaling in murine fibroblasts.
Fibroblasts were serum starved and treated with vehicle control A. DMSO, B. BP
(1μM), or C. LPS (5 ng/mL) for indicated times, and whole cell lysate was prepared
and analyzed by Western analysis with p-p65, p65, IκBα, and β-actin antibodies.
Relative phosphorylation of p65 was normalized by p65 for each sample and expressed
as fold. Relative expression of IκBα was normalized by β-actin for each sample and
expressed as fold. D. IκBα degradation and E. phosphorylation of p65 comparison
between each treatment with their own time 0. F. BP induced expression of IκBα and
p-p65 normalized with DMSO. Data are means + SE (n=3). * P < 0.05, ** P < 0.01,
and *** P < 0.001.
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A. DMSO

m
in

D. IκBα Degradation

B. MP (1μM)
m
in

E. p65 Phosphorylation

C. LPS
m
in

F. Normalized MP

Figure 3.6. Paraben activates NFκB signaling in human BRF fibroblasts.
Fibroblasts were serum starved and treated with A. vehicle control (DMSO), B. MP (1μM),
and C. LPS (5 ng/mL) for indicated times, and whole cell lysate was prepared and analyzed
by Western with p-p65, p65, IκBα, and β-actin antibodies. Relative phosphorylation of p65
was normalized by p65 for each sample and expressed as fold. Relative expression of IκBα
was normalized by β-actin for each sample and expressed as fold. D. IκBα degradation and
E. phosphorylation of p65 comparison between each treatment with their own time 0. F.
MP induced expression of IκBα and p-p65 normalized with DMSO. Data are means + SE
(n=3). * P < 0.05, ** P < 0.01, and *** P < 0.001.
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A. 3T3-L1 – 72 Hour

B. 3T3-L1 – 10 Day

C. BRF – 72 Hour

D. BRF – 10 Day

Figure 3.7. The conditioned media from paraben-treated fibroblasts promotes breast
cancer cell proliferation.
Fibroblasts were serum starved and treated with the negative (-), the vehicle control
(DMSO), MP (1μM), PP (1μM), BP (1μM), or LPS (5 ng/mL) for 72 hr (A. 3T3-L1 and
C. BRF) or 10 days (B. 3T3-L1 and D. BRF). CM was collected and incubated with
autobioluminescent MCF7 cell at a 1:1 ratio with fresh media. Average luminescence was
measured after 7 days and normalized to the vehicle control and expressed as fold. Data
are means ± SE (n=6). * P < 0.05, ** P < 0.01, and *** P < 0.001.
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Table 3.1. Primer sequences for qRT-PCR using SYBR green
Gene
36b4

Type
Murine

36B4 (RPLP0)

Human

Mmp9

Murine

MMP9

Human

Il1β

Murine

IL1β

Human

Cox2

Murine

COX2

Human

Cyp19a1

Murine

CYP19A1

Human

Sequence
FOR – GCTTCGTGTTCACCAAGGAGGA
REV – GTCCTAGACCAGTGTTCTGAGC
FOR – TGGTCATCCAGCAGGTGTTCGA
REV - ACAGACACTGGCAACATTGCGG
FOR – GCTGACTACGATAAGGACGGCA
REV – TAGTGGTGCAGGCAGAGTAGGA
FOR – GCCACTACTGTGCCTTTGAGTC
REV – CCCTCAGAGAATCGCCAGTACT
FOR – TGGACCTTCCAGGATGAGGACA
REV – GTTCATCTCGGAGCCTGTAGTG
FOR – CCACAGACCTTCCAGGAGAATG
REV – GTGCAGTTCAGTGATCGTACAGG
FOR – GCGACATACTCAAGCAGGAGCA
REV – AGTGGTAACCGCTCAGGTGTTG
FOR – CGGTGAAACTCTGGCTAGACAG
REV – GCAAACCGTAGATGCTCAGGGA
FOR – AAGCTCTGACGGGCCCTGGT
REV – ACGTAGCCCGAGGTGTCGGT
FOR – CACATCCTCAATACCAGGTCC
REV – CAGAGATCCAGACTCGCATG
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CHAPTER 4 :
PARABENS INDUCE INFLAMMATION IN STROMAL
ADIPOCYTES LEADING TO BREAST CANCER CELL
PROLIFERATION
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4.1.

Abstract

Background: Breast stromal inflammation is being identified as a key contributor to breast
carcinogenesis and breast cancer progression. Understanding the role and contribution of
each stromal cell type in breast carcinogenesis can lead to novel and effective therapeutic
or preventative strategies. Parabens are classified as a group of 4-hydroxybenzoic acid
esters, found ubiquitously in pharmaceuticals, food, personal care products, and industry
working as anti-microbial agents. Studies have shown that parabens are estrogenic
endocrine disruptive chemicals in experimental animals and can accumulate in a higher
amount in the breast cancer samples. Therefore, we hypothesize that parabens may promote
breast carcinogenesis by negatively modulating breast stromal adipocytes nearby breast
epithelial cells.

Methods: 3T3-L1 murine and human BRF adipocytes differentiated from respective
precursor cells were treated with the three most common parabens, methyl-, propyl-, and
butylparaben (MP, PP, and BP) at environmentally relevant doses (0.02, 0.1, and 1 µM)
for 6, 12, and 24 h. Gene expression was evaluated by RT-PCR. The effects of parabens
on NF-κB activation were studied by NF-κB reporter gene assays in differentiated 3T3-L1
CARΔ1 cells, which are engineered to express adenovirus receptor to enable adenoviral
DNA delivery, and by western analysis of p-p65 and IκBα degradation, two critical events
for NF-κB signaling pathways. Lastly, paraben-treated adipocyte conditioned media was
studied for their abilities to promote the proliferation of autobioluminescent MCF7 breast
cancer cells.
Results: A single exposure of BP increases Il1β, Cox2, and Mmp-9 at 6, 12 and 24 h in
murine adipocytes. A single exposure of MP and BP upregulates MMP-9 in human
adipocytes. Exposure of MP, PP, and BP downregulates IL1β and COX2 in human
adipocytes. The NF-κB pathway is activated by parabens shown by the induction of the
NF-B reporter gene and by increased phosphorylation of p65 and/or degradation of IBα
in murine adipocytes. In contrast, parabens only induce a modest response in human BRF
adipocytes. Consistently, the conditioned media from paraben-treated murine adipocytes,
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but not from human BRF adipocytes, promotes the proliferation of breast cancer MCF7
cells.

Conclusion: Parabens may play important roles in breast cancer progression by inducing
inflammation and aromatase expression in the breast stromal adipocytes.

4.2.

Introduction

Breast cancer continues to be the second most common cause of cancer-related death
among women of various races, despite the improving survival rate due to advances in
screening and treatment (ACS 2018). Hereditability accounts for less than 10% of breast
cancer incidences, where the remaining 90% are attributed to modifiable risk factors
(Darbre 2006, Darbre and Harvey 2014). A few modifiable environmental risk factors are
obesity, xenoestrogen exposure, alcohol consumption, hormone therapy, and oral
contraceptives (ACS 2018). The tumor microenvironment or stroma is the collection of
various cell types, adipocytes, fibroblasts, macrophage, neutrophils, and endothelial cells,
surrounding tumorigenic epithelial cells that provide a niche conducive to tumor growth.
The stroma has been found to play a critical role in angiogenesis, proliferation, invasion,
and metastasis and is greatly affected by these modifiable risk factors (Hanahan 2011).
Obesity, defined by the body mass index (BMI) ≥ 30 kg/m2 and characterized by excess of
adipose tissue accumulation, is a critical risk factor linked to breast cancer development,
recurrence, and decreased survivability (Chan, Vieira et al. 2014, Gathirua-Mwangi,
Zollinger et al. 2015, Playdon, Bracken et al. 2015). Adipose tissue functions as an
endocrine organ secreting soluble factors such as cytokines, adipokines, hormones, etc.,
and an obese individual can experience hypertrophy of adipocytes where the volume can
significantly multiply (Divella, De Luca et al. 2016). As adipocytes reach the limit of fat
containment, the integrity of the cell membrane becomes comprised and can induce
hypoxia and necrosis ultimately leading to inflammation (Divella, De Luca et al. 2016).
Adipocytes can also rupture from excess lipid accumulation, attracting macrophage to
remove debris further exacerbating inflammation via NF-κB activation (Divella, De Luca
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et al. 2016, Iyengar, Gucalp et al. 2016). Inflammation within the obese stroma signals the
release of cytokines, growth factors, and other proteins, thereby promoting changes
conducive to cancer proliferation, such as mitogenesis, angiogenesis, and ECM remodeling
(Radisky and Radisky 2007, Iyengar, Gucalp et al. 2016).

As the predominant cell type in breast tissue is the adipocyte, increased adiposity in the
stroma leads to enhanced estrogen production surrounding breast epithelial cells and raised
serum estradiol in obese individuals (Howe, Subbaramaiah et al. 2013, Hoy, Balaban et al.
2017). Moreover, inflammatory cytokines, PGE2, a COX2 product, and adipokines can
influence the production of estrogen biosynthesis through the induction of aromatase
(Brown 2014, Iyengar, Gucalp et al. 2016). Aromatase is a cytochrome P450 enzyme
encoded by the CYP19A1 gene that functions as the rate-limiting step in the conversion of
androgens to estrogen (Gerard and Brown 2018). Aromatase overexpression and activity
has been identified in the breast tissue of obese individuals and have a positive association
with the presence of crown-like structures (CLS), which develop when adipocytes become
necrotic (Howe, Subbaramaiah et al. 2013, Brown 2014, Gerard and Brown 2018). Taken
together, this suggests a critical role of stromal inflammation contributes to the obesityinflammation-estrogen axis (Gerard and Brown 2018).

It is recognized that environmental exposures particularly EDCs with estrogenic activities
pose as risk factors for breast cancer development (Cui, Balshaw et al. 2016). EDCs are
industrial chemicals utilized to enhance product sustainability and extend shelf-life but
have been identified to dysregulate endocrine systems, causing adverse health outcomes
(Cui, Balshaw et al. 2016). Parabens are alkyl esters of p-hydroxybenzoic acid incorporated
into personal care products, pharmaceuticals, food packaging, and paper products for their
anti-microbial and anti-fungal properties. The most common parabens used in the
commercial products and therefore often being detected in human biological samples are
methyl-, propyl-, and butylparaben (MP, PP, and BP) (Giulivo, Lopez de Alda et al. 2016).
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Parabens have been classified as weak EDCs, however, previous studies have identified at
low-dose exposures their ability to bind hormone receptors, enhance estrogenicity, and
promote progression breast cancer (Darbre and Harvey 2014). Moreover, total parabens
have been detected within normal breast tissue at an average concentration of 85 ng/g of
tissue with MP and PP in the highest concentrations at 16.6 and 16.8 ng/g tissue
respectively, indicating the presence of parabens around breast epithelial cells (Barr,
Metaxas et al. 2012). Furthermore, parabens have been detected in higher amounts in breast
cancer samples than their normal breast tissue controls, ranging from 17.3 ng/g tissue to
115 ng/g tissue (Darbre, Aljarrah et al. 2004). Furthermore, parabens have been shown to
be capable to promote breast epithelial cell growth, however, it is not clear whether
parabens also negatively affect breast stroma (Darbre and Harvey 2008).

The objective of this study was to determine the effects of common parabens (MP, PP, and
BP) at environmentally achievable doses (0.02, 0.1, and 1 µM) on mRNA expression of
inflammatory genes and Cyp19A1 in the stromal adipocytes from murine and human
origins and the ability of exposed adipocytes to enhance breast cancer cell proliferation.
We demonstrate that parabens induce the upregulation of inflammatory genes (Il1β and
Cox2) and ECM remodeling gene Mmp9 and induce activation of the NF-κB pathway. We
also show paraben-exposed adipocytes conditioned media induces substantial MCF7
proliferation.

4.3.

Materials and Methods

4.3.1

Reagents

Methylisobutylxanthine (MIX), dexamethasone (DEX) and insulin (Ins) were purchased
from Sigma Aldrich (St Louis, MO). Dimethyl sulfoxide (DMSO); methyl-, propyl-, and
butylparaben were from Acros Organics (>99%, Thermo Fisher Scientific, Pittsburg, PA).
Ultra-pure lipopolysaccharide (LPS) was from List Biological Laboratories (Campbell,
CA). Phospho-NF-κB p65 (Ser536) (no. 3033) and NF-κB -p65 (D14E12) XP (no. 8242)
were purchased from Cell Signaling Technology. IκBα (C-21): sc-371 was purchased from
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Santa Cruz Biotechnology. Anti-β-actin (AC-15) (no. A1978) was from Sigma-Aldrich.
Neomycin (G-418) was purchased from Research Products International (Mount Prospect,
IL)

4.3.2. Cell Culture
Murine 3T3-L1 fibroblasts (ATCC, Manassas, VA) were grown in Dulbecco’s Modified
Eagles medium (DMEM) containing 10% calf serum (HyClone).

Murine 3T3-L1

expressing coxsackievirus and adenovirus receptor (CARΔ1) cells were donated by Dr.
Orlicky (Orlicky DJ 2001) and were grown in DMEM containing 10% fetal bovine serum
(FBS) (Atlanta Biological, Flowery Branch, GA).

Human subcutaneous breast fat

preadipocytes (BRF) (Zenbio, NC) were grown in Preadipocyte Medium (PM-1) according
to the manufacturer’s instructions (Zenbio, NC). Human Autobioluminescent MCF7 cell
line was a gift from Dr. Ripp (490 BioTech, Inc., Knoxville, TN) (Xu, Ripp et al. 2014)
and was grown in DMEM containing 10% FBS with G-418. All were grown in 5% CO2,
37oC conditions.

4.3.3. Immortalization of Primary BRF Cells
Immortalization of primary BRF cells was completed by infecting the BRF cells with
lentivirus encoding the SV40LT antigen. SV40LT antigen was cloned into a lentiviral
vector carrying the neomycin phosphotransferase gene (Alwin Prem Anand, Gowri Sankar
et al. 2012). Lentivirus particles were generated by co-transfecting SV40LT vector with
packaging (psPAX2) and envelope (pMD2.G) vectors (Addgene; Boston, MA) in
HEK293Ta cells (GeneCopoeia, Inc; Rockville, MD) using FuGENE® HD transfection
reagent (Promega Corporation; Madison, WI) following manufacturer’s guidelines. Once
developed, the lentivirus particles were used to infect the BRF cells. Stable cell lines were
selected using G418 antibiotic (300 µg/ml) for two weeks.
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4.3.4. Adipocyte Differentiation
3T3-L1 fibroblasts were grown to confluency, and on the day of confluency cells were
treated with DMEM containing 10% FBS, 0.5mM MIX, 10μg/mL Ins, and 1μM of DEX
for 3 days (day 0-3). The cells were then grown in DMEM containing 10% FBS and
10μg/mL Ins for 2 days (day 4-5). Lastly, the cells are maintained in their differentiated
state with DMEM containing 10% FBS (day 6-7). BRF fibroblasts were grown to
confluency, on the day of confluency cells were treated with Adipocyte Differentiation
Media (DM-2) (Zenbio, NC) for 7 days. After 7 days, DM-2 was removed and Adipocyte
Maintenance Media (AM-1) (Zenbio, NC) was added for an additional 7 days.

4.3.5. Oil red O Staining and Quantification
Lipid accumulation after differentiation of adipocytes was stained with oil red O (ORO) as
previously described (Hu, Chen et al. 2013).

4.3.6. Paraben Treatment
To detect the inflammatory effects of low-dose paraben on 3T3-L1 or BRF fibroblasts, a
single exposure

of 0.02, 0.10, or 1.0 μM methyl-, propyl-, or butylparaben was

administered in low-serum conditions, 0.25% calf serum (HyClone) for 3T3-L1 cells and
1% charcoal-stripped fetal bovine serum (CS-FBS) (HyClone) for BRF cells. DMSO and
LPS were used as vehicle control and positive control, respectively.

4.3.7. RNA and Quantitative Real-Time PCR
Total RNA was prepared from adipocytes using TRIzol (Invitrogen Coorporation,
Carlsbad,

CA)

following

the

manufacturer’s

protocol.

NanoDrop

ND-1000

Spectrophotometer (NanoDrop Technologies, Wilmington, DE) was utilized to measure
total RNA. Reverse transcription was completed with the High-Capacity cDNA Reverse
Transcription kit (Thermo Fisher Scientific) following the manufacturer’s protocol. mRNA
expression of adipocyte inflammation markers and housekeeping gene 36B4 (Table S1)
were analyzed quantitatively using PowerUp SYBR Green Master Mix (Thermo Fisher
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Scientific) in a 96-well PCR plates with an ABI 7900HT Real-Time PCR System with
cycle conditions of 50oC 2 min, 95 oC 2 min, and 40 cycles of 95oC for 15s/60oC for 1 min.
The relative gene expression was calculated utilizing 2 (-ΔΔCt) method and normalized with
36B4.

4.3.8. Reporter Gene Assays
3T3-L1 CARΔ1 were seeded in a 24-well plate format and infected with adenovirus
encoding NF-κB-Luc reporter gene and adenovirus encoding β-galactosidase (β-gal)
control plasmid for 15 h, as described previously (Purohit, Hu et al. 2013). After infection,
the cells were differentiated following the 3T3-L1 protocol. The cells were probed with
various parabens for 6 and 12 h. The cell lysate was prepared utilizing Reporter Lysis 5X
Buffer (Promega). Reporter luciferase activity was analyzed using GloMax Luminometer
(Promega, Madison, WI) and normalized by β-gal activities.

4.3.9. Western Blot Analysis
Total cell lysates of adipocytes were prepared, centrifuged, and protein concentrations
measured by Pierce BCA protein assay kit (Thermo Fisher Scientific). 20-40 μg of total
cell lysate were run through a polyacrylamide gel and transferred to polyvinylidene
difluoride membrane (Bio-Rad). The membrane was blocked in 20 mM Tris-HCl, 137 mM
NaCl, and 0.1% Tween 20 (pH 7.4) containing 5% nonfat milk or 5% bovine serum
albumin (BSA). The membrane was immunoblotted with primary antibodies at 4 oC
overnight followed by secondary antibody conjugated with horseradish peroxidase. The
signal was detected utilizing SuperSignal West Pico PLUS Chemiluminescent Substrate
(Thermo Scientific), HyBlot CL autoradiography film (Denville Scientific), and a Konica
SRX-101A film processor. Quantification by densitometry was performed by the ImageJ
software.
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4.3.10. Conditioned Media Collection
3T3-L1 and BRF fibroblasts were seeded into 60 mm dishes and probed to differentiate
following their respective protocols. Each plate of cells was treated with MP, PP, BP (each
at 1 µM) or controls (DMSO or LPS) in 5% CS-FBS. After 72 h or 10 days, the treatment
was removed, and the cells were washed twice with phenol-red free (PRF) media
(HyClone). To collect the conditioned media (CM), cells were cultured for 48 h in PRF
media with 5% CS-FBS, penicillin, and streptomycin. After 48 h, the media was collected
and centrifuged at 600 rpm for 5 minutes. The supernatant was transferred into a fresh tube
and stored at 4oC before use.

4.3.11. Bioluminescent imaging
Autobioluminescent MCF7 cells were plated at 30% confluency in duplicate wells of 24well opaque, clear bottom plates (Labnet/Corning Inc., Cary, NC). After attachment
overnight, MCF7 cells were washed with PRF media and treated with CM: 5% CS-FBS
PRF media in a 1:1 ratio. Treatment persisted for 7 days with changing CM at day 4. On
day 7, plates were imaged utilizing a CCD-based IVIS Lumina imaging system
(PerkinElmer). Autobioluminescent readings were acquired 3 times at 10 min intervals
according to the manufacturer’s instructions.

4.3.12. Statistical Analysis
All data are presented as means + SE. Measurements were performed in triplicates unless
otherwise indicated. Statistical analysis was performed using SigmaPlot 14.0 (Systat
Software). One-way ANOVA on ranks or one-way ANOVA with repeated measures
followed by multiple comparison tests (Student-Newman-Keuls method) were used to
determine the differences among treatment groups or time points. Student’s t-tests were
conducted to evaluate LPS compared to the control. The level of significance was set at P
< 0.05. The effects of treatment and plate location on fold change of average radiance were
analyzed using two-way ANOVA analysis for each time point in 3T3-L1 and human BRF
adipocytes.Post hoc multiple comparisons were performed with Tukey’s adjustment.
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Statistical significance was identified at the level of 0.05. Analyses were conducted in SAS
9.4 TS1M4 for Windows 64x (SAS institute Inc., Cary, NC).

4.4.

Results

4.4.1. Parabens Induce mRNA Expression of inflammatory genes and CYP19a1 in
Murine 3T3-L1 Adipocytes and Human BRF Adipocytes
3T3-L1 fibroblasts were first differentiated following the 7-day differentiation protocol
(Figure 4.1.A.) and then exposed to MP, PP, or BP or their vehicle control at 0.02, 0.1, or
1 µM for 6, 12, or 24 h. LPS was included as a positive control. Typically, there is ~100%
and ~50% differentiation of 3T3-L1 and BRF cells, respectively (Figure 4.1.A-B). The
inflammatory response to parabens differs depending on the length of the side chain, dose,
and time of exposure. Propylparaben and BP significantly upregulated inflammatory Il1β
mRNA expression in 3T3-L1 adipocytes. Compared to the vehicle control (DMSO), PP
increased maximally ~ 7 fold of Il1β mRNA expression at 1 µM at 12 h (p<0.001), but was
not sustained at 24 h (p<0.001) of exposure. BP at all tested doses significantly increased
Il1β mRNA expression at 6, 12, and 24 h of exposure. At 1 µM BP increased the maximal
~ 17 fold of Il1β mRNA expression at 6 h (p<0.01) and ~ 3 fold (p<0.05) and ~ 4.5 fold
(p<0.001) at 12 and 24 h, respectively (Figure 4.2.A). In contrast, MP did not influence
Il1β mRNA expression at 6 or 12 h but downregulated it at 24 h (Figure 4.2.A). A maximal
2 fold Il1β mRNA level was induced by LPS at 24h of exposure (Figure 4.2.A).
In addition to Il1β, we also examined Mmp9 mRNA expression, a key MMP in matrix
remodeling in breast cancer growth. Even though LPS significantly upregulated ~ 3.5 fold
of Mmp9 mRNA expression at 6 h (p<0.001), reaching ~ 8 fold at 12 h (p<0.001), and ~
3.5 fold at 24 h exposure, there was not much effects by parabens except that PP increased
3 fold at 12 h at 1 µM (p<0.001) and BP increased 2.5 fold at 6 h at 1 µM (p<0.001) and
2.5 fold at 12 h at 0.02 µM (p<0.01) compared to DMSO (Figure 4.2.B). We examined the
effects of parabens on Cox2 mRNA expression in adipocytes as COX2 upregulation is
greatly associated with progression of many cancers, including breast cancer (Denkert,
Winzer et al. 2004, Sano, Kogashiwa et al. 2018). Propylparaben and BP significantly
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upregulated Cox2 mRNA expression at 6, 12, and 24 h (p<0.05). Propylparaben induced ~
2.5 fold of Cox2 mRNA expression at 6 h at 1 µM, which has remained at 12 h but subsided
at 24 h. All tested doses of BP induced significant Cox2 mRNA at 6 h and 24 h, with a
maximal 4.5 fold at 1 µM (p<0.001) compared to the control. In contrast, LPS only
increased 2 fold of Cox2 mRNA expression at 6 h (p<0.05) (Figure 4.2.C).

Lastly, we analyzed mRNA expression of Cyp19a1, the enzyme responsible for the
conversion of androstenedione and estrone to estrogen (Gerard and Brown 2018). Parabens
tested, PP and BP in particular, significantly upregulated Cyp19a1 mRNA expression. PP
at all tested concentrations significantly upregulated Cyp19a1 mRNA expression at both 6
and 12 h (p<0.001). PP at 1µM induced ~ 4 fold of Cyp19a1 mRNA expression at 6 h,
which was increased to ~ 6 fold at 12 h and subsided to the basal level at 24 h. BP at all
tested concentrations significantly upregulated Cyp19a1 mRNA expression at 6, 12, and
24 h. Butylparaben at 1 µM induced a maximal 10 fold of Cyp1a mRNA expression at 6 h
(p<0.001), which was decreased to 3.5 fold at 12 and 24 h (p<0.05) compared to the vehicle
control. In contrast, LPS only increased ~ 2 fold of Cyp19a1 mRNA expression at 24 h
exposure (p<0.001) (Figure 4.2.D).

Similar to those of murine adipocytes, all three parabens also induced differential responses
in the human BRF adipocytes, depending on the length of the side chain, dose, and time of
exposure (Figure 4.3.). Butylparaben induced maximal ~ 3 fold of IL1β mRNA expression
at 12 h at 0.1 µM but downregulated it at 6 and 24 h at all tested in human concentrations
in the BRF adipocytes (Figure 4.3.A). Methylparaben and PP both downregulated IL1β
mRNA expression at 6 h while MP and PP had minimal effect at 12 and 24 h (Figure
4.3.A). In contrast, LPS induced a maximal 2.5 fold of IL1β mRNA expression at 12 h and
had minimal effects at 6 and 24 h (Figure 4.3.A).

In contrast, all three parabens induced more robust responses of MMP9 in human BRF
cells. Compared to the controls, BP induced ~ 2 fold of MMP9 mRNA expression at 6 h
and ~ 3.5 fold at 24 h at 1 µM. MP induced ~ 4 fold of MMP9 mRNA at 0.1 µM (p<0.01)
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and ~ 4.5 fold at 1 µM (p<0.05) only at 24 h (p<0.05) (Figure 4.3.B). PP had no significant
induction of MMP9 mRNA expression. LPS induced ~ 2.5 fold of MMP9 mRNA
expression at 6 h in human BRF cells (Figure 4.3.B). All three parabens downregulate
COX2 mRNA expression at 6 and 12 h with no significant changes at 24 h (Figure 4.3.C).

Lastly, CYP19A1 mRNA expression was significantly downregulated by all three tested
parabens at 6 h with no significant response at 12 or 24 h except BP at 0.02 µM at 12 h of
exposure, which increased CYP1A1 to ~ 1.3 fold compared to the vehicle control (p<0.05).
Propylparaben also significantly upregulates CYP19A1 mRNA expression by 1.5 fold at
0.02 µM at 24 h (p<0.01). Similarly, LPS does not induced an increase of CYP19A1 mRNA
expression at 6, 12, or 24 h in human BRF adipocytes (Figure 4.3.D).

4.4.2. Parabens Regulate NF-κB Signaling in Murine and Human Derived Adipocytes
Next, we investigated the effects of paraben on the NF-κB signaling pathway, which is
critical signaling that drives inflammatory gene expression. First, we investigated NF-κB
activation using NF-κB-responsive luciferase reporter assays. We validated the infection
efficiency of adenovirus-mediated infection in differentiated 3T3-L1 CARΔ1 adipocytes
using adenoviral GFP (Figure 4.4.A). Then 3T3-L1 CARΔ1 fibroblasts were infected with
adenovirus encoding an NF-κB-Luc receptor and then differentiated. At 6 h, MP activated
NF-κB in 3T3-L1 CARΔ1 adipocytes only at 0.02 µM (p<0.05). LPS induced ~ 3 fold of
activation at 6 h, which was attenuated by an NF-κB inhibitor CAPE (Figure 4.4.B).
Similar to the gene expression results, PP induced a modest but significant NF-κB
activation in 3T3-L1 adipocytes only at 1 µM and at 12 h (p<0.05). (Figure 4.3.C).
Butylparaben induced ~ 1.5 fold of activation only at 0.02 µM and at 12 h (p<0.05). In
contrast, LPS induced 4 fold of NF-κB activation in 3T3-L1 adipocytes at 12 h.
We further confirmed paraben-induced NF-κB activation in 3T3-L1 cells by analyzing the
phosphorylation of p65 and degradation of IκBα, two key events leading to NF-κB
activation (Figure 4.5.A). Quantification of densitometry showed that compared to the
respective vehicle control (DMSO), BP at 1 μM induced the degradation of IκBα beginning
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at 30 min (p<0.001) (Figure 4.5.D) and phosphorylation of p65 also at 30 min (p<0.05)
(Figure 4.5.E). LPS also showed significant degradation of IκBα and phosphorylation of
p65 beginning at 5 min (p<0.001). When MP NF-κB activation was normalized by DMSO,
IκBα degradation had a minimal response, however p65 phosphorylation was significantly
enhanced demonstrating the bimodal activation at 5 and 30 minutes (Figure 4.5.F). NF-κB
activation by BRF cells was not tested as gene expression analysis showed a decrease in
inflammatory mRNA markers.

4.4.3. Conditioned Media from Parabens-Treated Adipocytes Regulates Breast Cancer
Cell Proliferation
To explore the effects of paraben exposure on stromal induction and cancer progression,
we evaluated the effects of the CM collected from paraben-treated adipocytes on the
proliferation of human breast cancer cells MCF7. We evaluated CM collected after shortterm (72 h) and long-term (10 days) exposure of parabens on both 3T3-L1 and BRF
adipocytes. The CM was then used to induce the proliferation of autobioluminescent MCF7
cells. At 72 h, PP induced greater proliferation of MCF7 cells compared to those of other
parabens, but it did not reach statistical significance. Moreover, paraben stimulated
proliferation is not significantly greater than the vehicle control (DMSO) (Figure 4.6.A).
In contrast, the CM collected from BP, but not MP or PP-treated 3T3-L1 adipocytes for 10
days induced significant proliferation of autobioluminescent MCF7 cells compared to the
vehicle control (p<0.05) (Figure 4.6.B). Interestingly, the CM from both MP and BP
exposed human BRF adipocytes appeared to suppress the proliferation of MCF7 cells at
72 h (p<0.001), whereas the CM from PP exposed BRF adipocytes had no effects compared
to the vehicle control at 72 h (Figure 4.6.C). Lastly, MCF7 cell proliferation is diminished
upon treatment with the CM from MP, PP, and BP exposed adipocytes for 10 days
(p<0.001), confirming downregulated gene expression results (Figure 4.6.D).
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4.5.

Discussion and Conclusion

To our knowledge, our study is the first to demonstrate the effect of parabens at
environmental achievable doses influence mRNA expression of inflammatory genes and
aromatase, CYP19A1, in murine and human adipocytes differentiated from human breast
stromal cells. Using conditioned media, we determined the effect of secretion from lowdose parabens exposed adipocytes on breast cancer cell growth. Our results demonstrate
that typical exposure to parabens within the environment induce a pro-inflammatory
response and upregulate aromatase Cyp19a1 in murine adipocytes. In contrast, parabens
were found to be protective against inflammation by downregulation of pro-inflammatory
genes and CYP19A1 in human BRF adipocytes. Consistently, the conditioned media from
paraben-exposed murine adipocytes, but not from human BRF adipocytes, promotes breast
cancer cell proliferation.

Parabens are preservatives utilized in industry including personal care products,
pharmaceuticals, food, etc. causing a daily ubiquitous presence in the environment (Darbre
and Harvey 2008, Darbre and Harvey 2014). These chemicals found in creams and lotions
are absorbed dermally while absorption through the gastrointestinal (GI) tract is another
avenue, particularly for food and pharmaceutical products. Esterases in the skin and in the
GI tract hydrolyze parabens quickly, however intact parabens are detected in the blood,
breast milk, placenta, and urine (Sandanger, Huber et al. 2011, Zhao, Liu et al. 2014,
Kolatorova 2017, Shen, Liang et al. 2017). Within 5 h unconjugated parabens are present
at low levels in human serum, at 12 h hydrolyzed metabolites are no longer present in
serum, and by 24 h conjugated parabens are the all that remain (Shin, Shin et al. 2019). All
paraben and metabolites are excreted by 72 h after a single exposure (Shin, Shin et al.
2019).

Parabens influence a variety of endocrine-related diseases including obesity as obesogens
and reproductive diseases in both men and women (Hu, Chen et al. 2013, Kirchhof and de
Gannes 2013, Hu, Kennedy et al. 2016, Guerra, Sanabria et al. 2017). Some of these
diseases are related to the estrogenic nature of parabens, however, they do influence other
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endocrine pathways. Parabens have been identified to promote breast cancer cell
proliferation, invasion, and metastasis possible through modulation of estrogen receptor,
human epidermal growth factor receptor, androgen receptor, G protein-coupled estrogen
receptor 1. (Darbre and Harvey 2014, Lillo, Nichols et al. 2017).

A breast cancer tumor requires the cooperation of the surrounding stromal cells to create a
niche that provides the perfect environment for growth and proliferation (Hanahan 2011).
The stroma is a complex network of fibroblasts, adipocytes, immune cells, endothelial
cells, macrophages, etc. all communicating with each other and adjacent epithelial cells
(Bussard, Mutkus et al. 2016). Stromal adipocytes are the most abundant in the obese breast
and function as the estrogen source for postmenopausal women. Adipocytes are endocrine
organs, capable of secreting adipokines, pro-inflammatory cytokines, chemokines,
estrogen, and other factors, which then influence surround breast epithelial cells through
cross-talk. Adipocytes can be trained to support and enable tumor growth and therapy
resistance through local inflammation (Majidinia and Yousefi 2017). In addition to the
ability to store energy in the form of lipids, adipocytes release glycerol and fatty acids into
the stroma, which are necessary for the synthesis of epithelial cell membranes and
metabolic components (Hoy, Balaban et al. 2017). Adipocytes found in a cancerous
microenvironment have increased expression of matrix metalloproteinases (MMPs) and
pro-inflammatory cytokines, including interleukin (IL1β) and cyclooxygenase (COX2)
(Bussard, Mutkus et al. 2016, Divella, De Luca et al. 2016, Iyengar, Gucalp et al. 2016).
Our findings add to the established literature by demonstrating parabens' abilities to induce
inflammation and ECM remodeling gene in murine adipocytes, creating a conducive
environment promoting breast cancer cell growth.

In this study, we have aspired to address the effects of common, household parabens at
environmentally achievable doses on stromal adipocytes and the subsequent effect of
exposed adipocytes on breast cancer cell proliferation. Our results demonstrate that
parabens at low concentrations upregulate mRNA for Cox2, Il1β, and Cyp19a1 in murine
adipocytes and upregulate MMP9 in human adipocytes in type, dose, and exposure time82

dependent manner. In murine adipocytes, parabens elicited an inflammatory response with
the increasing length of the alkyl side-chain (MP < PP < BP), where BP most often induced
the most significant response over time.

The increased inflammatory mRNA expression in murine adipocytes is confirmed by the
activation of NF-κB reporter and the signaling events of phosphorylation of p65 and IBα
degradation. Additionally, the timing of activation of NF-κB reporter mimics the gene
expression in that MP induces a response in a shorter period of time compared to that of
PP or BP. Although we demonstrate parallel effects of NF-B activation with inflammatory
gene Il-1β and Cox-2 by parabens, whether inflammatory effects induced by parabens in
adipocytes are mediated by NF-B pathway need to be confirmed in the future. We did not
identified that parabens directly activate NF-B pathway, but they likely activate other
signaling pathways that network with NF-B leading to activation. More studies are
necessary to elucidate the exact signaling mechanisms activated in stromal adipocytes upon
paraben treatment, especially considering parabens ability to bind and activate multiple
hormone and protein receptors.

In contrast, parabens induced a modest response of inflammatory genes and CYP19A1 in
human adipocytes, demonstrating a species-specific response to parabens in the stromal
adipocytes. A single exposure of MP and BP only provokes a higher and sustainable MMP9
mRNA expression in the human BRF adipocytes, suggesting that these human adipocytes
may be more influential in ECM remodeling than inflammation. Interestingly, the
downregulation of inflammatory gene expression upon paraben treatment suggests a
protective effect in human adipocytes.

Furthermore, we aimed to determine the effect of paraben-stimulated adipocytes can
stimulate the proliferation of breast cancer cells. Conditioned media was acquired after
treating adipocytes with parabens and washing to remove any residual intact or hydrolyzed
parabens. The CM was used in a 1:1 ratio with fresh media to support the growth of
autobioluminescent MCF7 cells. The CM collected 72 h from the paraben-exposed murine
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adipocytes did not stimulate the proliferation of MCF7 cells, but the CM collected 10 days
from BP-exposed adipocytes was sufficient to enhance MCF cell proliferation. The finding
of secretion from inflamed adipocytes inducing proliferation of breast cancer cells agrees
with the understood effects of inflammation in the stroma on breast cancer (Howe,
Subbaramaiah et al. 2013, Gerard and Brown 2018). Interestingly, the CM collected from
paraben-exposed human adipocytes showed decreased proliferation of MCF7 cells, which
is consistent with the suppression of IL1β, COX2 and CYP19A1 mRNA expression by
parabens, suggesting that parabens could be protective in these human adipocytes.

Previous studies have indicated that body fatness is protective against breast cancer in
premenopausal women and deleterious in postmenopausal women (Amadou, Ferrari et al.
2013, Nichols, Schoemaker et al. 2017). Therefore, a future study comparing the effects of
CM collected from both pre- and postmenopausal stromal adipocytes with known BMI on
breast cancer cell proliferation could elucidate these results. Additional studies to solidify
results such as identifying the soluble factors within the CM from the adipocytes and the
molecular mechanisms activated from paraben-exposed adipocytes are also necessary.

In conclusion, we have shown that parabens, common preservatives in household products,
at environmentally achievable doses promote mRNA expression of pro-inflammatory
genes and Cyp19a1 in 3T3-L1 adipocytes. The inflammatory response of upregulated Il1β
and Cox2 expression induced by parabens are consistent with NF-κB activation. In
contrast, parabens only induce a modest response in human BRF adipocytes. Further
studies are needed to study the effects of long term with repeated exposure of parabens in
adipocytes and to confirm the stromal response to parabens in vivo to further define the
roles of parabens in breast cancer development.
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4.7. Appendix
A. 3T3-L1

B. BRF

Figure 4.1. Adipocyte differentiation of 3T3-L1 and the human BRF cells.
The cell images demonstrating 3T3-L1 (A) and BRF fibroblasts (B) differentiation into
adipocytes and lipid accumulation (stained by ORO lipophilic stain) following standard
protocols.

89

A. Il1β

B. Mmp9

C. Cox2

D. Cyp19a1

Figure 4.2. Parabens induce mRNA expression of inflammatory genes and Cyp19a1
in 3T3-L1 adipocytes.
3T3-L1 adipocytes were treated with selected parabens (0.02, 0.10, 1.0μM) for the
indicated time period. DMSO was the vehicle control and LPS was the positive control.
Relative mRNA expression of inflammatory markers (A. Il1β, B. Mmp9, C. Cox2, and D.
Cyp19a1) was analyzed. The relative mRNA expression was normalized to 36B4 and
expressed as fold of that of the DMSO sample. Data are mean + SE (n = 3). One-way
ANOVA on Ranks was performed followed by multiple comparison tests with Student
Newman-Keuls method to compare with the control. * , p < 0.05, **, p < 0.01, and ***, p
< 0.001.
90

A. IL1β

B. MMP9

C. COX2

D. CYP19A1

Figure 4.3. Parabens induce mRNA expression of inflammatory genes and CYP19A1
in human BRF adipocytes.
BRF adipocytes were treated with selected parabens (0.02, 0.10, 1.0μM) for the indicated
time period. DMSO was the vehicle control and LPS was the positive control. Relative
mRNA expression of inflammatory markers (A. IL1β, B. MMP9, C. COX2, and D.
CYP19A1) was analyzed. The relative mRNA expression was normalized to 36B4 and
expressed as fold of that of the DMSO sample. Data are mean + SE (n = 3). One-way
ANOVA on Ranks was performed followed by multiple comparison tests with Student
Newman-Keuls method to compare with the control. * - p < 0.05, ** - p < 0.01, and *** p < 0.001.
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A.

B. 6 Hours

C. 12 Hours

Figure 4.4. Parabens activate NFκB reporter in murine adipocytes.
3T3-L1 CARΔ1 fibroblasts were infected with adenovirus containing NFκB-Luc and
β-galactosidase (β-gal) for 15 h and then differentiated following 3T3-L1 differentiation
protocol. A. GFP luminescence verifying infection of adenovirus into 3T3-L1 CARΔ1
adipocytes. Adipocytes were stimulated with 0.02, 0.1, or 1 μM MP, PP, or BP along
with DMSO and 5 ng/mL LPS as controls for B. 6 h and C. 12 h. Reporter gene assays
were conducted and relative luciferase activity was normalized by β-gal for each sample
and expressed as fold. Data are means ± SE (n=3). * P < 0.05, ** P < 0.01, and *** P <
0.001.
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A. DMSO

D. IκBα Degradation

B. BP (1μM)
E. p65 Phosphorylation

C. LPS

F. Normalized BP

Figure 4.5. Paraben activates NFκB signaling in murine adipocytes.
Adipocytes were serum starved and treated with vehicle control A. DMSO, B. BP
(1μM), or C. LPS (5 ng/mL) for indicated times, and whole cell lysate was prepared
and analyzed by Western analysis with p-p65, p65, IκBα, and β-actin antibodies.
Relative phosphorylation of p65 was normalized by p65 for each sample and expressed
as fold. Relative expression of IκBα was normalized by β-actin for each sample and
expressed as fold. D. IκBα degradation and E. phosphorylation of p65 comparison
between each treatment with their own time 0. F. BP induced expression of IκBα and
p-p65 normalized with DMSO. Data are means + SE (n=3). * P < 0.05, ** P < 0.01, and
*** P < 0.001.
Figure 6. Paraben activates NFκB signaling in murine adipocytes. Adipocytes were
serum starved and treated with vehicle control A. DMSO, B. BP (1μM), or C. LPS (5
ng/mL) for indicated times, and whole cell lysate was prepared and analyzed by Western
analysis with p-p65, p65, IκBα, and β-actin antibodies. Relative phosphorylation of p6593
was normalized by p65 for each sample and expressed as fold. Relative expression of
IκBα was normalized by β-actin for each sample and expressed as fold. D. IκBα
degradation and E. phosphorylation of p65 comparison between BP (1μM) and controls.
Data are means + SE (n=3). * P < 0.05, ** P < 0.01, and *** P < 0.001.

A. 3T3-L1 – 72 Hour

B. 3T3-L1 – 10 Day

C. BRF – 72 Hour

D. BRF – 10 Day

Figure 4.6. The conditioned media from paraben-treated adipocytes promotes
breast cancer cell proliferation.
Adipocytes were serum starved and treated with the negative (-), vehicle control
(DMSO), MP (1μM), PP (1μM), BP (1μM), or LPS (5 ng/mL) for 72 h (A. 3T3-L1 and
C. BRF) and 10 days (B. 3T3-L1 and D. BRF). CM was collected and incubated with
autobioluminescent MCF7 cell at a 1:1 ratio with fresh media. Average radiance was
measured after 7 days and normalized to the vehicle control and expressed as fold. Data
are means ± SE (n=6). * P < 0.05, ** P < 0.01, and *** P < 0.001.
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CHAPTER 5 :
CONCLUSIONS AND FUTURE DIRECTIONS
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5.1. Conclusions
This dissertation contains two primary experiments detailed in Chapters 3 and 4. Chapter
3 details the inflammatory effect of MP, PP, and BP at environmentally achievable doses
on fibroblasts. Low-dose (i.e., 0.2–1 µM) paraben exposure led to the upregulation of
inflammatory mRNA expression including Il1β and Cox2 in both murine 3T3-L1 and
human BRF fibroblasts. MMP9 mRNA expression was also upregulated by parabens in
murine cells but more significantly in human fibroblasts. These results demonstrate the
ability for a single exposure of parabens to fibroblasts to influences inflammatory and
matrix remodeling gene expression patterns. Additionally, parabens increased the mRNA
expression of Cyp19A1 or aromatase implicating parabens’ ability to increase estrogen
production. Activation of the NF-κB signaling pathway was confirmed by reporter gene
and western blot analysis, consistent with an inflammatory gene response. The wavering
trends of IκBα degradation and p65 phosphorylation could be due to paraben’s ability to
activate a variety of different signaling pathways that ultimately result in influencing NFκB. The CM of the paraben treated fibroblasts enhanced proliferation of MCF7 breast
epithelial cells compared to their vehicle control. Therefore, parabens at low-doses are able
to stimulate inflammation in stromal fibroblasts, which in turn are able to promote the
proliferation of breast cancer cells.

Chapter 4 addresses the inflammatory effect of MP, PP, and BP on stromal adipocytes.
Paraben exposures led to an upregulation of inflammatory Il1β, Mmp9, and Cox2 in murine
adipocytes, but surprisingly decreased Il1β and Cox2 mRNA expression in the human
adipocytes. Moreover, both 3T3-L1 and BRF adipocytes induced the upregulation of
Cyp19a1 or aromatase upon paraben treatment. Parabens activated the NF-κB pathway as
indicated by the reporter gene and western blot analysis in 3T3-L1 adipocytes. Similar to
the fibroblasts, more detailed analysis of the upstream activation of NF-κB could aid in
understanding the variance in inflammatory gene expression and NF-κB patterns.
Consistently, long-term (10 days) exposure of parabens to differentiated 3T3-L1
adipocytes led to CM that enhanced MCF7 cell proliferation. However, paraben exposed
human adipocytes suppressed MCF7 cell proliferation compared to vehicle control
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(DMSO) similar to gene expression, demonstrating a species-specific response of
adipocytes to paraben exposure.

In summary, both murine and human stromal fibroblasts and adipocytes showed response
when exposed to environmentally relevant doses of paraben. Murine fibroblasts and
adipocytes activate inflammatory signaling pathways and upregulating cytokines that are
closely associated with breast cancer progression. Murine fibroblasts and adipocytes have
consistent upregulation of inflammatory mRNA expression as well as NF-κB activation
and MCF7 growth promotion. Even though human fibroblasts follow suit with murine
cells, human adipocytes appear to have an alternate effect leading to protection against
inflammation.

5.2. Significance of the Study
Breast cancer is a complex disease that affects women globally. As improvements are being
made with treatment causing a decline in death rates, women are still being diagnosed with
invasive breast cancer at rates similar to previous decades. With the stroma play a critical
role in breast cancer, understanding the contribution from each cell type is necessary to
identify potential prevention or treatment strategies. In breast cancer microenvironment,
fibroblasts and adipocytes are the two most common stromal cells.

The study of the negative effects of environmental chemical exposure on breast cancer via
a stromal inflammation can give new insight into addressing breast cancer from a different
perspective. As parabens, a commonly used anti-microbial found in personal care products,
food, pharmaceuticals, and more, have the ability to induce inflammation in stromal cells,
the local inflammation surround breast epithelial cells is enhanced. Inflammation functions
as a promoter to cancer progression in that it stimulates the opening of DNA strands,
increasing vulnerability to mutations. As human are exposed to fresh parabens multiple
times a day, unconjugated parabens found in serum stimulate inflammation in stromal cells
continuously leading to an inflamed microenvironment. If there are abnormal epithelial
cells already present in the stroma (e.g., DCIS), this paraben-induced inflammation can
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lead to the promotion of breast cancer. Therefore, this study indicates that parabens at daily
human exposure levels can induce stromal inflammation, which is then to enhance breast
cancer progression.

When addressing obesity and breast cancer, aromatase is often thought of to be the link
bringing the two together. Aromatase functions in the conversion of estrogens to estradiol,
and greater levels of estradiol contacting ER+ breast cancers can obviously stimulate
proliferation. Parabens are shown to increase the expression of aromatase in fibroblasts and
adipocytes. Assuming the increase in aromatase leads to increased estrogen secretion into
the conditioned media, both fibroblasts and adipocytes can be influence the amount of
estrogen present in the microenvironment ultimately leading to breast cancer progression
in ER+ breast cancers.

Therefore, this study demonstrates how parabens have the potential to enhance breast
cancer proliferation solely from parabens’ effect on stromal cells.

5.3. Limitations and Future Directions
As an exploratory study to identify the effects of parabens on stromal cells, there are several
limitations to this study. A single exposure to parabens was used in both fibroblasts and
adipocytes, however, individuals are exposed to parabens multiple times per day for years.
Therefore, longer term exposures could provide additional insights into parabens genomic
effects such as altered epigenetics.

Moreover, the contents of the CM were not analyzed and doing so via mass spectrometry
would provide more information on which cytokines from paraben stimulation were
translated into protein and secreted triggering breast cancer cell proliferation. Additionally,
identifying the signaling pathway within the breast cancer epithelial cells that were
enhanced upon treatment with CM could also solidify the findings. Therefore, conducting
a more mechanistic signaling study with the MCF7 breast cancer cells would be a logical
next step.
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The human stromal cells utilized in this model had a difficult time differentiating after
being infected with the lentivirus to make them immortal. With additional funding, a better
technique would be to analyze primary stromal cells without infection. Primary stromal
cells differentiated into adipocytes would be a better translatable model. Acquiring breast
stromal cells from both premenopausal and postmenopausal women of both normal and
obese BMI would enhance the study as well. Comparing the effects of BMI and menopause
could show differences in the imposition of parabens and the effect of stromal
inflammation of breast cancer cells.

Since only in vitro studies were performed, future studies are needed to confirm the effects
of parabens in breast stromal cells and breast cancer progression in vivo via xenograft of
paraben treated stromal cells mixed with tumorigenic MCF7 cells in immunodeficient
mice.

To enhance this study, the utilization of breast epithelial cells representing all possible
cancer types would provide significantly more information on the influence of inflamed
stroma. For instance, imposing conditioned media upon non-cancerous breast epithelial
cells (MCF10A), ER+/PR-/HER2- cells (MCF7), ER+/PR+/HER2- cells (T-47D), ER/PR-/HER2+ cells (SkBr3), and triple negative breast cancer cells (MDA-MB-231). The
utilization of all these cancer cell types could expand our understanding of how parabeninduced stromal inflammation on breast cancer development and progression and could
lead to novel strategies for breast cancer treatment and prevention.
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